Cover
Cover - USD ($) $ in Billions | 12 Months Ended | ||
Apr. 30, 2024 | May 31, 2024 | Oct. 31, 2023 | |
Cover [Abstract] | |||
Document Type | 10-K | ||
Document Annual Report | true | ||
Document Period End Date | Apr. 30, 2024 | ||
Current Fiscal Year End Date | --04-30 | ||
Document Transition Report | false | ||
Entity File Number | 001-38675 | ||
Entity Registrant Name | Elastic N.V. | ||
Entity Incorporation, State or Country Code | P7 | ||
Entity Tax Identification Number | 98-1756035 | ||
Title of 12(b) Security | Ordinary shares, Par Value €0.01 Per Share | ||
Trading Symbol | ESTC | ||
Security Exchange Name | NYSE | ||
Entity Well-known Seasoned Issuer | Yes | ||
Entity Voluntary Filers | No | ||
Entity Current Reporting Status | Yes | ||
Entity Interactive Data Current | Yes | ||
Entity Filer Category | Large Accelerated Filer | ||
Entity Small Business | false | ||
Entity Emerging Growth Company | false | ||
ICFR Auditor Attestation Flag | true | ||
Document Financial Statement Error Correction | false | ||
Entity Shell Company | false | ||
Entity Public Float | $ 7.5 | ||
Entity Common Stock, Shares Outstanding | 101,715,185 | ||
Documents Incorporated by Reference | DOCUMENTS INCORPORATED BY REFERENCE Portions of the registrant’s definitive proxy statement relating to the registrant’s 2024 annual general meeting of shareholders are incorporated by reference into Part III of this Annual Report on Form 10-K where indicated. Such definitive proxy statement will be filed with the U.S. Securities and Exchange Commission within 120 days after the end of the registrant’s fiscal year ended April 30, 2024. | ||
Entity Central Index Key | 0001707753 | ||
Amendment Flag | false | ||
Document Fiscal Year Focus | 2024 | ||
Document Fiscal Period Focus | FY |
Audit Information
Audit Information | 12 Months Ended |
Apr. 30, 2024 | |
Audit Information [Abstract] | |
Auditor Name | PricewaterhouseCoopers LLP |
Auditor Location | San Jose, California |
Auditor Firm ID | 238 |
Consolidated Balance Sheets
Consolidated Balance Sheets - USD ($) $ in Thousands | Apr. 30, 2024 | Apr. 30, 2023 |
Current assets: | ||
Cash and cash equivalents | $ 540,397 | $ 644,167 |
Restricted cash | 2,692 | 2,473 |
Marketable securities | 544,002 | 271,041 |
Accounts receivable, net of allowance for credit losses of $4,979 and $3,409 as of April 30, 2024 and April 30, 2023, respectively | 323,011 | 260,919 |
Deferred contract acquisition costs | 78,030 | 55,813 |
Prepaid expenses and other current assets | 42,765 | 39,867 |
Total current assets | 1,530,897 | 1,274,280 |
Property and equipment, net | 5,453 | 5,092 |
Goodwill | 319,380 | 303,642 |
Operating lease right-of-use assets | 20,506 | 19,997 |
Intangible assets, net | 20,620 | 29,104 |
Deferred contract acquisition costs, non-current | 114,509 | 95,879 |
Deferred tax assets | 225,544 | 7,412 |
Other assets | 5,657 | 8,076 |
Total assets | 2,242,566 | 1,743,482 |
Current liabilities: | ||
Accounts payable | 26,075 | 35,151 |
Accrued expenses and other liabilities | 75,292 | 63,532 |
Accrued compensation and benefits | 93,691 | 76,483 |
Operating lease liabilities | 12,187 | 12,749 |
Deferred revenue | 663,846 | 528,704 |
Total current liabilities | 871,091 | 716,619 |
Deferred revenue, non-current | 30,293 | 34,248 |
Long-term debt, net | 568,612 | 567,543 |
Operating lease liabilities, non-current | 12,898 | 13,942 |
Other liabilities, non-current | 21,487 | 12,233 |
Total liabilities | 1,504,381 | 1,344,585 |
Commitments and contingencies (Notes 8 and 9) | ||
Shareholders’ equity: | ||
Preference shares, €0.01 par value; 165,000,000 shares authorized, 0 shares issued and outstanding as of April 30, 2024 and April 30, 2023 | 0 | 0 |
Ordinary shares, par value €0.01 per share: 165,000,000 shares authorized; 101,705,935 shares issued and outstanding as of April 30, 2024 and 97,366,947 shares issued and outstanding as of April 30, 2023 | 1,070 | 1,024 |
Treasury stock | (369) | (369) |
Additional paid-in capital | 1,750,729 | 1,471,584 |
Accumulated other comprehensive loss | (21,638) | (20,015) |
Accumulated deficit | (991,607) | (1,053,327) |
Total shareholders’ equity | 738,185 | 398,897 |
Total liabilities and shareholders’ equity | $ 2,242,566 | $ 1,743,482 |
Consolidated Balance Sheets (Pa
Consolidated Balance Sheets (Parenthetical) $ in Thousands | Apr. 30, 2024 USD ($) shares | Apr. 30, 2024 € / shares | Apr. 30, 2023 USD ($) shares | Apr. 30, 2023 € / shares |
Allowance for doubtful accounts | $ | $ 4,979 | $ 3,409 | ||
Ordinary shares, shares authorized (in shares) | 165,000,000 | |||
Convertible Preference Shares | ||||
Preference shares, par value ( in € / shares) | € / shares | € 0.01 | € 0.01 | ||
Preference shares, shares authorized (in shares) | 165,000,000 | 165,000,000 | ||
Preference shares, shares issued (in shares) | 0 | 0 | ||
Preference shares, shares outstanding (in shares) | 0 | 0 | ||
Ordinary Shares, Par Value of €0.01 | ||||
Ordinary shares, par value (in € / shares) | € / shares | € 0.01 | € 0.01 | ||
Ordinary shares, shares authorized (in shares) | 165,000,000 | 165,000,000 | ||
Ordinary shares, shares issued (in shares) | 101,705,935 | 97,366,947 | ||
Ordinary shares, shares outstanding (in shares) | 101,705,935 | 97,366,947 |
Consolidated Statements of Oper
Consolidated Statements of Operations - USD ($) $ in Thousands | 12 Months Ended | ||
Apr. 30, 2024 | Apr. 30, 2023 | Apr. 30, 2022 | |
Revenue | |||
Total revenue | $ 1,267,321 | $ 1,068,989 | $ 862,374 |
Cost of revenue | |||
Total cost of revenue | 330,079 | 296,626 | 232,194 |
Gross profit | 937,242 | 772,363 | 630,180 |
Operating expenses | |||
Research and development | 341,951 | 313,454 | 273,761 |
Sales and marketing | 559,648 | 503,537 | 406,658 |
General and administrative | 160,628 | 143,247 | 123,441 |
Restructuring and other related charges | 4,917 | 31,297 | 0 |
Total operating expenses | 1,067,144 | 991,535 | 803,860 |
Operating loss | (129,902) | (219,172) | (173,680) |
Interest expense | (26,132) | (25,159) | (20,716) |
Other income (expense), net | 33,278 | 27,454 | (3,393) |
Loss before income taxes | (122,756) | (216,877) | (197,789) |
(Benefit from) provision for income taxes | (184,476) | 19,284 | 6,059 |
Net income (loss) | $ 61,720 | $ (236,161) | $ (203,848) |
Net earnings (loss) per share attributable to ordinary shareholders | |||
Basic (in dollars per share) | $ 0.62 | $ (2.47) | $ (2.20) |
Diluted (in dollars per share) | $ 0.59 | $ (2.47) | $ (2.20) |
Weighted-average shares used to compute net earnings (loss) per share attributable to ordinary shareholders | |||
Basic (in shares) | 99,646,231 | 95,729,844 | 92,547,145 |
Diluted (in shares) | 103,980,132 | 95,729,844 | 92,547,145 |
Subscription | |||
Revenue | |||
Total revenue | $ 1,176,606 | $ 984,762 | $ 798,770 |
Cost of revenue | |||
Total cost of revenue | 246,285 | 219,306 | 178,204 |
Services | |||
Revenue | |||
Total revenue | 90,715 | 84,227 | 63,604 |
Cost of revenue | |||
Total cost of revenue | $ 83,794 | $ 77,320 | $ 53,990 |
Consolidated Statements of Comp
Consolidated Statements of Comprehensive Income (Loss) - USD ($) $ in Thousands | 12 Months Ended | ||
Apr. 30, 2024 | Apr. 30, 2023 | Apr. 30, 2022 | |
Statement of Comprehensive Income [Abstract] | |||
Net income (loss) | $ 61,720 | $ (236,161) | $ (203,848) |
Other comprehensive loss: | |||
Unrealized loss on available-for-sale securities, net of taxes | (1,728) | (71) | 0 |
Foreign currency translation adjustments | 105 | (1,814) | (10,025) |
Other comprehensive loss | (1,623) | (1,885) | (10,025) |
Total comprehensive income (loss) | $ 60,097 | $ (238,046) | $ (213,873) |
Consolidated Statements of Shar
Consolidated Statements of Shareholders’ Equity - USD ($) $ in Thousands | Total | Ordinary Shares | Treasury Shares | Additional Paid-in Capital | Accumulated Other Comprehensive Loss | Accumulated Deficit |
Beginning balance (in shares) at Apr. 30, 2021 | 90,533,985 | |||||
Beginning balance at Apr. 30, 2021 | $ 450,831 | $ 948 | $ (369) | $ 1,071,675 | $ (8,105) | $ (613,318) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||
Fair value of replacement equity awards attributable to pre-acquisition service | 1,266 | 1,266 | ||||
Issuance of ordinary shares upon exercise of stock options (in shares) | 2,563,287 | |||||
Issuance of ordinary shares upon exercise of stock options | 36,410 | $ 29 | 36,381 | |||
Conversion of redeemable convertible preference shares to ordinary shares upon initial public offering (in shares) | 1,077,642 | |||||
Issuance of ordinary shares upon release of restricted stock units | 0 | $ 13 | (13) | |||
Stock-based compensation | 140,799 | 140,799 | ||||
Net income (loss) | (203,848) | (203,848) | ||||
Foreign currency translation | (10,025) | (10,025) | ||||
Ending balance (in shares) at Apr. 30, 2022 | 94,174,914 | |||||
Ending balance at Apr. 30, 2022 | 415,433 | $ 990 | (369) | 1,250,108 | (18,130) | (817,166) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||
Issuance of ordinary shares upon exercise of stock options (in shares) | 1,127,036 | |||||
Issuance of ordinary shares upon exercise of stock options | 17,471 | $ 12 | 17,459 | |||
Conversion of redeemable convertible preference shares to ordinary shares upon initial public offering (in shares) | 2,064,997 | |||||
Issuance of ordinary shares upon release of restricted stock units | 0 | $ 22 | (22) | |||
Stock-based compensation | 204,039 | 204,039 | ||||
Net income (loss) | (236,161) | (236,161) | ||||
Foreign currency translation | (1,885) | (1,885) | ||||
Ending balance (in shares) at Apr. 30, 2023 | 97,366,947 | |||||
Ending balance at Apr. 30, 2023 | 398,897 | $ 1,024 | (369) | 1,471,584 | (20,015) | (1,053,327) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||
Issuance of ordinary shares upon exercise of stock options (in shares) | 1,292,375 | |||||
Issuance of ordinary shares upon exercise of stock options | 20,919 | $ 14 | 20,905 | |||
Conversion of redeemable convertible preference shares to ordinary shares upon initial public offering (in shares) | 2,701,448 | |||||
Issuance of ordinary shares upon release of restricted stock units | 0 | $ 28 | (28) | |||
Issuance of ordinary shares under employee stock purchase plan (in shares) | 345,165 | |||||
Issuance of ordinary shares under employee stock purchase plan | 19,135 | $ 4 | 19,131 | |||
Stock-based compensation | 239,137 | 239,137 | ||||
Net income (loss) | 61,720 | 61,720 | ||||
Foreign currency translation | (1,623) | (1,623) | ||||
Ending balance (in shares) at Apr. 30, 2024 | 101,705,935 | |||||
Ending balance at Apr. 30, 2024 | $ 738,185 | $ 1,070 | $ (369) | $ 1,750,729 | $ (21,638) | $ (991,607) |
Consolidated Statements of Cash
Consolidated Statements of Cash Flows - USD ($) $ in Thousands | 12 Months Ended | ||
Apr. 30, 2024 | Apr. 30, 2023 | Apr. 30, 2022 | |
Cash flows from operating activities | |||
Net income (loss) | $ 61,720 | $ (236,161) | $ (203,848) |
Adjustments to reconcile net income (loss) to cash provided by operating activities: | |||
Depreciation and amortization | 17,999 | 20,233 | 19,728 |
Amortization of premium and accretion of discount on marketable securities, net | (8,808) | (772) | 0 |
Amortization of deferred contract acquisition costs | 78,549 | 68,900 | 60,738 |
Amortization of debt issuance costs | 1,069 | 1,023 | 803 |
Non-cash operating lease cost | 11,010 | 10,880 | 8,636 |
Asset impairment charges | 0 | 6,242 | 0 |
Stock-based compensation expense | 239,137 | 204,039 | 140,612 |
Deferred income taxes | (217,195) | (2,007) | (2,430) |
Foreign currency transaction loss (gain) | (1,930) | 1,386 | (1,984) |
Other | (34) | 44 | 98 |
Changes in operating assets and liabilities, net of impact of business acquisitions: | |||
Accounts receivable, net | (63,519) | (46,353) | (62,187) |
Deferred contract acquisition costs | (119,834) | (102,017) | (96,755) |
Prepaid expenses and other current assets | (2,875) | 1,323 | (3,427) |
Other assets | 1,906 | 8,525 | 825 |
Accounts payable | (9,998) | 6,304 | 21,036 |
Accrued expenses and other liabilities | 18,144 | 4,310 | 27,192 |
Accrued compensation and benefits | 17,357 | 8,324 | 17,775 |
Operating lease liabilities | (12,391) | (11,405) | (8,888) |
Deferred revenue | 134,595 | 95,616 | 83,780 |
Net cash provided by operating activities | 148,762 | 35,662 | 5,672 |
Cash flows from investing activities | |||
Purchases of property and equipment | (3,450) | (2,684) | (2,485) |
Business acquisitions, net of cash acquired | (19,100) | 0 | (119,854) |
Purchases of marketable securities | 536,833 | 270,268 | 0 |
Maturities and redemptions of marketable securities | 271,423 | 0 | 0 |
Capitalization of internal-use software | 0 | 0 | (4,932) |
Net cash used in investing activities | (287,960) | (272,952) | (127,271) |
Cash flows from financing activities | |||
Proceeds from the issuance of debt | 0 | 0 | 575,000 |
Proceeds from issuance of ordinary shares under employee stock purchase plan | 19,135 | 0 | 0 |
Proceeds from issuance of ordinary shares upon exercise of stock options | 20,919 | 17,471 | 36,410 |
Payments of debt issuance costs | 0 | 0 | (9,283) |
Net cash provided by financing activities | 40,054 | 17,471 | 602,127 |
Effect of exchange rate changes on cash, cash equivalents, and restricted cash | (4,407) | 2,822 | (20,599) |
Net (decrease) increase in cash, cash equivalents, and restricted cash | (103,551) | (216,997) | 459,929 |
Cash, cash equivalents, and restricted cash, beginning of period | 646,640 | 863,637 | 403,708 |
Cash, cash equivalents, and restricted cash, end of period | 543,089 | 646,640 | 863,637 |
Supplemental disclosures of cash flow information | |||
Cash paid for interest | 25,063 | 24,136 | 12,995 |
Cash paid for income taxes, net | 24,219 | 11,581 | 3,979 |
Cash paid for operating lease liabilities | 14,000 | 13,136 | 10,101 |
Supplemental disclosures of non-cash investing and financing information | |||
Changes in property and equipment included in accounts payable | 398 | 121 | 150 |
Operating lease right-of-use assets for new lease obligations | 11,539 | 10,902 | 8,992 |
Acquisition-related indemnity holdback | $ 3,000 | $ 0 | $ 6,000 |
Summary of Significant Accounti
Summary of Significant Accounting Policies | 12 Months Ended |
Apr. 30, 2024 | |
Accounting Policies [Abstract] | |
Summary of Significant Accounting Policies | Summary of Significant Accounting Policies Basis of Presentation The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and include the financial statements of the Company and its wholly-owned subsidiaries. All intercompany transactions and accounts have been eliminated in consolidation. Fiscal Year The Company’s fiscal year ends on April 30. References to fiscal 2024, for example, refer to the fiscal year ended April 30, 2024. Use of Estimates and Judgments The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Such estimates and assumptions include, but are not limited to, standalone selling price (“SSP”) for each distinct performance obligation included in customer contracts with multiple performance obligations, the period of benefit for deferred contract acquisition costs, allowance for credit losses, valuation of stock-based compensation, fair value of ordinary shares in periods prior to the Company’s initial public offering, fair value of acquired intangible assets and goodwill, useful lives of acquired intangible assets and property and equipment, whether an arrangement is or contains a lease, discount rate used for operating leases, and valuation allowance for deferred income taxes. The Company bases these estimates on historical and anticipated results, trends and various other assumptions that it believes are reasonable under the circumstances, including assumptions as to future events. Estimates and assumptions about future events and their effects cannot be determined with certainty and therefore require the exercise of judgment. As of the date of issuance of these financial statements, the Company is not aware of any specific event or circumstance that would require the Company to update its estimates, judgments or revise the carrying value of the Company’s assets or liabilities. These estimates may change, as new events occur and additional information is obtained, and are recognized in the consolidated financial statements as soon as they become known. Actual results could differ from those estimates and any such differences may be material to the Company’s financial statements. Foreign Currency The reporting currency of the Company is the U.S. dollar. The Company determines the functional currency of each subsidiary in accordance with ASC 830, Foreign Currency Matters, based on the currency of the primary economic environment in which each subsidiary operates. Items included in the financial statements of such subsidiaries are measured using that functional currency. The Company periodically re-assesses its operations to determine if previous conclusions are still valid. Changes in functional currencies are applied prospectively if the operations encounter a significant and permanent change. For the subsidiaries where the U.S. dollar is the functional currency, foreign currency denominated monetary assets and liabilities are re-measured into U.S. dollars at current exchange rates and foreign currency denominated nonmonetary assets and liabilities are re-measured into U.S. dollars at historical exchange rates. Gains or losses from foreign currency re-measurement and settlements are included in other income (expense), net in the consolidated statement of operations. For the years ended April 30, 2024, 2023, and 2022, the Company recognized re-measurement losses of $3.4 million, $0.4 million, and $3.6 million, respectively. For subsidiaries where the functional currency is other than the U.S. dollar, the Company uses the period-end exchange rates to translate assets and liabilities, the average monthly exchange rates to translate revenue and expenses, and historical exchange rates to translate shareholders’ equity into U.S. dollars. The Company records translation gains and losses in accumulated other comprehensive loss as a component of shareholders’ equity in the consolidated balance sheet. Other Comprehensive Loss The Company’s other comprehensive loss includes net income (loss), unrealized loss on available-for-sale securities, net of taxes, and foreign currency translation adjustments. Cash, Cash Equivalents and Restricted Cash The Company considers all highly liquid investments, including money market funds with an original maturity of three months or less at the date of purchase, to be cash equivalents. The carrying amount of the Company’s cash equivalents approximates fair value, due to the short maturities of these instruments. The Company’s restricted cash consists primarily of cash deposits with financial institutions in support of letters of credit in favor of landlords for non-cancelable lease agreements. Cash, cash equivalents, and restricted cash as reported in the Company’s consolidated statements of cash flows includes the aggregate amounts of cash and cash equivalents and the restricted cash as shown on the consolidated balance sheet. Cash, cash equivalents, and restricted cash as reported in the Company’s consolidated statements of cash flows consists of the following (in thousands): As of April 30, 2024 2023 Cash and cash equivalents $ 540,397 $ 644,167 Restricted cash 2,692 2,473 Cash, cash equivalents and restricted cash $ 543,089 $ 646,640 Marketable Securities The Company’s marketable securities consist of highly liquid investment-grade fixed-income securities. The Company determines the appropriate classification of its investments at the time of purchase and reevaluates such designation at each balance sheet date. The Company has classified and accounted for its marketable securities as available-for-sale debt securities as the Company may sell these securities at any time for use in its current operations or for other purposes, including prior to maturity. As a result, the Company has classified its marketable securities within current assets on the consolidated balance sheets. Available-for-sale debt securities are recorded at fair value each reporting period. Premiums and discounts are amortized or accreted over the life of the related available-for-sale debt security as an adjustment to yield using the effective interest method. Interest income is recognized when earned. Unrealized gains and losses on these marketable securities are reported as a separate component of accumulated other comprehensive loss until realized. Realized gains and losses are determined based on the specific identification method and are reported in other income (expense), net in the consolidated statements of operations. For available-for-debt securities in an unrealized loss position, the Company first assesses whether it intends to sell the security or it is more likely than not that the Company will be required to sell the security before the recovery of its entire amortized cost basis. If either of these criteria is met, the security’s amortized cost basis is written down to fair value through other income (expense), net in the consolidated statements of operations. If neither of these criteria are met, the Company evaluates whether the decline in fair value below amortized cost is due to credit or non-credit related factors. In making this assessment, the Company considers the extent to which fair value is less than amortized cost, any changes to the rating of the security by a rating agency, and any adverse conditions specifically related to the security, among other factors. Credit related unrealized losses are recognized as an allowance for expected credit losses of available-for-sale securities on the consolidated balance sheets with a corresponding charge in other income (expense), net in the consolidated statements of operations. Non-credit related unrealized losses are included in accumulated other comprehensive income (loss). Fair Value of Financial Instruments The Company follows ASC 820, Fair Value Measurements and Disclosures, with respect to assets and liabilities that are measured at fair value. Under this standard, fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the reporting date. The accounting guidance establishes a three-tiered hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value as follows: • Level 1: Observable inputs, such as unadjusted quoted prices in active markets for identical assets or liabilities at the measurement date. • Level 2: Observable inputs, other than Level 1 prices, such as quoted prices in active markets for similar assets and liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. • Level 3: Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. The Company’s financial instruments consist of cash equivalents, marketable securities, mutual fund investments held in a rabbi trust, accounts receivable, accounts payable, and accrued liabilities. Cash equivalents are stated at amortized cost, which approximates fair value at the balance sheet dates, due to the short period of time to maturity. Marketable securities and mutual fund investments are recorded at fair value. Accounts receivable, accounts payable and accrued liabilities are stated at their carrying value, which approximates fair value due to the short time to the expected receipt or payment date. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk are primarily cash, cash equivalents, restricted cash, marketable securities, and accounts receivable. The primary focus of the Company’s investment strategy is to preserve capital and meet liquidity requirements. The Company maintains its cash accounts with financial institutions where, at times, deposits exceed federal insurance limits. The Company invests its excess cash in highly-rated money market funds and in short-term investments. The Company extends credit to customers in the normal course of business. The Company performs credit analyses and monitors the financial health of its customers to reduce credit risk. Trade accounts receivable are recorded at the invoiced amount and do not bear interest. Management performs ongoing credit evaluations of customers and maintains allowances for potential credit losses on customers’ accounts when deemed necessary. Accounts Receivable, Unbilled Accounts Receivable and Allowance for Credit Losses Accounts receivable primarily consists of amounts billed currently due from customers. The Company’s accounts receivable are subject to collection risk. Gross accounts receivable are reduced for this risk by an allowance for credit losses. This allowance is for estimated losses resulting from the inability of the Company’s customers to make required payments. The Company determines the need for an allowance for credit losses based upon various factors, including past collection experience, credit quality of the customer, age of the receivable balance, and current economic conditions, as well as specific circumstances arising with individual customers. Accounts receivables are written off against the allowance when management determines a balance is uncollectible and the Company no longer actively pursues collection of the receivable. The Company does not typically offer right of refund in its contracts. The allowance for credit losses reflects the Company’s best estimate of probable losses inherent in the Company’s receivables portfolio. Unbilled accounts receivable represents amounts for which the Company has recognized revenue, pursuant to the Company’s revenue recognition policy, for fulfilled obligations, but not yet billed. Capitalized Software Development and Implementation Costs Software development costs for software to be sold, leased, or otherwise marketed are expensed as incurred until the establishment of technological feasibility, at which time those costs are capitalized until the product is available for general release to customers and amortized over the estimated life of the product. Technological feasibility is established upon the completion of a working prototype that has been certified as having no critical bugs and is a release candidate. To date, costs to develop software that is marketed externally have not been capitalized as the current software development process is essentially completed concurrently with the establishment of technological feasibility. As such, all related software development costs are expensed as incurred and included in research and development expense in the consolidated statement of operations. Costs related to software acquired, developed, or modified solely to meet the Company’s internal requirements, with no substantive plans to market such software at the time of development, and costs related to the development of web-based product are capitalized during the application development stage. Costs incurred during the preliminary planning and evaluation stage of the project and during the post-implementation operational stage are expensed as incurred. Costs incurred during the application development stage of the project are capitalized. The Company also capitalizes qualifying implementation costs incurred in a hosting arrangement that is a service contract. These costs are amortized on a straight-line basis over the expected life of the service contract, including consideration of the reasonably certain renewal periods, and are presented in the same income statement line items as the service for the related hosting arrangement. The Company did not capitalize any costs during the years ended April 30, 2024 and 2023. All previously capitalized costs are recorded in other assets, non-current on the consolidated balance sheet. Property and Equipment Property and equipment are recorded at cost and depreciated over their estimated useful lives using the straight-line method. Upon retirement or sale, the cost of assets disposed of and the related accumulated depreciation are removed from the financial statements and any resulting gain or loss is reflected within the consolidated statement of operations. There was no material gain or loss incurred as a result of retirement or sale in the periods presented. Repair and maintenance costs are expensed as incurred. Leases Leases arise from contractual obligations that convey the right to control the use of identified property, plant or equipment for a period of time in exchange for consideration. The Company determines whether an arrangement is or contains a lease at inception, based on whether there is an identified asset and whether the Company controls the use of the identified asset throughout the period of use. At the lease commencement date, the Company determines the lease classification between finance and operating and recognizes a right-of-use asset and corresponding lease liability for each lease component. A right-of-use asset represents the Company’s right to use an underlying asset and a lease liability represents the Company’s obligation to make payments during the lease term. The operating lease right-of-use asset also includes any lease payments made and excludes lease incentives. Lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. The Company accounts for lease components and non-lease components as a single lease component. Leases with an initial term of twelve months or less are classified as short-term leases and therefore are not recognized on the consolidated balance sheets and are expensed on a straight-line basis within the consolidated statement of operations. The lease liability is initially measured as the present value of the remaining lease payments over the lease term. The discount rate used to determine the present value is the Company’s incremental borrowing rate unless the interest rate implicit in the lease is readily determinable. The Company estimates its incremental borrowing rate based on the information available at lease commencement date for borrowings with a similar term. The right-of-use asset is initially measured as the present value of the lease payments, adjusted for initial direct costs, prepaid lease payments to lessors and lease incentives. Acquisitions When the Company acquires a business, the Company allocates the purchase price, which is the sum of the consideration provided and may consist of cash, equity or a combination of the two, in a business combination to the identifiable assets and liabilities of the acquired business at their estimated respective fair values. The Company recognizes and measures contract assets and contract liabilities acquired in a business combination on the acquisition date in accordance with ASC 606, Revenue from Contracts with Customers. The excess of the purchase price over the amount allocated to the identifiable assets and liabilities, if any, is recorded as goodwill. Determining the fair value of assets acquired and liabilities assumed requires management to use significant judgment and estimates, including, but not limited to, the selection of valuation methodologies, estimates of future revenue and cash flows, costs to rebuild developed technology, discount rates and selection of comparable companies. The Company’s estimates of fair value are based upon assumptions believed to be reasonable, but which are inherently uncertain and unpredictable and, as a result, actual results may differ from estimates. During the measurement period, the Company may record adjustments to the assets acquired and liabilities assumed, with the corresponding offset to goodwill. Upon the conclusion of the measurement period, any subsequent adjustments are recorded to other income (expense), net in the consolidated statement of operations. When the Company issues stock-based or cash awards to an acquired company’s shareholders, the Company evaluates whether the awards are consideration or compensation for post-acquisition services. The evaluation includes, among other things, whether the vesting of the awards is contingent on the continued employment of the acquired company’s shareholders beyond the acquisition date. If continued employment is required for vesting, the awards are treated as compensation for post- acquisition services and recognized as expense over the requisite service period. Acquisition-related transaction costs incurred by the Company are not included as a component of consideration transferred, but are accounted for as an operating expense in the period in which the costs are incurred. The results of businesses acquired in a business combination are included in the Company’s consolidated financial statements from the date of acquisition. Goodwill Goodwill represents the excess of the purchase price over the fair value of net assets acquired in business combinations accounted for using the acquisition method for accounting and is not amortized. The Company tests goodwill for impairment at least annually, in the fourth quarter of each year, or more frequently if events or changes in circumstances indicate that this asset may be impaired. For the purposes of impairment testing, the Company has determined that it has one operating segment and one reporting unit. The Company’s test of goodwill impairment starts with a qualitative assessment to determine whether it is necessary to perform a quantitative goodwill impairment test. If qualitative factors indicate that the fair value of the reporting unit is more likely than not less than its carrying amount, then a quantitative goodwill impairment test is performed. For the quantitative analysis, the Company compares the fair value of its reporting unit to its carrying value. If the estimated fair value exceeds book value, goodwill is considered not to be impaired and no additional steps are necessary. However, if the fair value of the reporting unit is less than book value, then goodwill will be impaired by the amount that the carrying amount exceeds the implied fair value. There was no impairment of goodwill recorded for the years ended April 30, 2024, 2023, and 2022. Acquired Intangible Assets Acquired amortizable intangible assets are amortized on a straight-line basis over the estimated useful lives of the assets. Useful life Developed technology 4-5 Customer relationships 4 Trade names 4 Impairment of Long-Lived Assets The Company evaluates the recoverability of long-lived assets, including property and equipment and amortizable acquired intangible assets, for possible impairment whenever events or circumstances indicate that the carrying amount of such assets may not be fully recoverable. Such events and changes may include: significant changes in performance relative to expected operating results, significant changes in asset use, significant negative industry or economic trends, and changes in the Company’s business strategy. Recoverability of these assets is measured by a comparison of the carrying amounts to the future undiscounted cash flows the assets are expected to generate. If such review indicates that the carrying amount of long-lived assets is not recoverable, the carrying amount of such assets is reduced to fair value. During the year ended April 30, 2023, the Company recorded asset impairment charges comprising impairment of operating lease right-of-use assets and the associated furniture, equipment, and leasehold improvements of $5.1 million and $1.1 million, respectively, for exited leased office spaces associated with the Company’s restructuring plan. See Note 16 for further details. The Company determined that there were no events or changes in circumstances that indicated that its long-lived assets were impaired during the years ended April 30, 2024 and 2022. In addition to the recoverability assessment, the Company periodically reviews the remaining estimated useful lives of property and equipment and amortizable intangible assets. If the estimated useful life assumption for any asset is changed, the remaining unamortized balance would be depreciated or amortized over the revised estimated useful life, on a prospective basis. Revenue Recognition The Company generates revenue primarily from the sale of self-managed subscriptions (which include licenses for proprietary features, support, and maintenance) and from the sale of software-as-a-service (“SaaS”) subscriptions. The Company also generates revenue from services, which consist of consulting and training. Under ASC 606, the Company recognizes revenue when its customer obtains control of promised goods or services in an amount that reflects the consideration that the Company expects to receive in exchange for those goods or services. The Company’s contracts include varying terms and conditions, and identifying and evaluating the impact of these terms and conditions on revenue recognition requires significant judgment. In determining the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its agreements, the Company performs the following steps: (i) identification of the contract with a customer; The Company contracts with its customers through order forms, which in some cases are governed by master sales agreements. The Company determines that it has a contract with a customer when the order form has been approved, each party’s rights regarding the products or services to be transferred can be identified, the payment terms for the services can be identified, the Company has determined the customer has the ability and intent to pay and the contract has commercial substance. The Company applies judgment in determining the customer’s ability and intent to pay, which is based on a variety of factors, including the customer’s historical payment experience or, in the case of a new customer, credit, reputation and financial or other information pertaining to the customer. At contract inception the Company evaluates whether two or more contracts should be combined and accounted for as a single contract and whether the combined or single contract includes more than one performance obligation. The Company has concluded that its contracts with customers generally do not contain warranties that give rise to a separate performance obligation. (ii) identification of the performance obligations in the contract; Performance obligations promised in a contract are identified based on the products and services that will be transferred to the customer that are both capable of being distinct, whereby the customer can benefit from the products or services either on their own or together with other resources that are readily available from third parties or from the Company, and are distinct in the context of the contract, whereby the transfer of the products and services is separately identifiable from other promises in the contract. The Company’s self-managed subscriptions include both a license providing the right to use proprietary features in its software, as well as an obligation to provide support (on both open source and proprietary features) and maintenance. The Company’s SaaS products provide access to hosted software as well as support, which the Company considers to be a single performance obligation. Services-related performance obligations relate to the provision of consulting and training services. These services are distinct from subscriptions and do not result in significant customization of the software. (iii) determination of the transaction price; The transaction price is the total amount of consideration the Company expects to be entitled to in exchange for the subscriptions and services in a contract. Variable consideration is included in the transaction price if, in the Company’s judgment, it is probable that a significant future reversal of cumulative revenue under the contract will not occur. None of the Company’s contracts contain a significant financing component. (iv) allocation of the transaction price to the performance obligations; and If the contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. For contracts that contain multiple performance obligations, the Company allocates the transaction price to each performance obligation based on a relative SSP. The SSP is determined based on the prices at which the Company separately sells these products assuming the majority of these prices fall within a pricing range. In instances where SSP is not directly observable, such as when the Company does not sell the software license separately, the Company derives the SSP using information that may include market conditions and other observable and unobservable inputs which can require significant judgment. There is typically more than one SSP for individual products and services due to the stratification of those products and services by quantity, term of the subscription, sales channel and other circumstances. If one of the performance obligations is outside of the SSP range, the Company allocates the transaction price considering the midpoint of the SSP range. The Company also considers if there are any additional material rights inherent in a contract and, if so, the Company allocates a portion of the transaction price to such rights based on a relative SSP. (v) recognition of revenue when the Company satisfies each performance obligation; Revenue is recognized at the time the related performance obligation is satisfied by transferring the promised product or service to the customer. Revenue for SaaS offerings that relate to a specified amount of services is recognized on a consumption basis as the customers utilize the services. Revenue from SaaS offerings that are stand-ready arrangements is recognized ratably over the contract period as the Company satisfies the performance obligation. The Company’s self-managed subscriptions include both upfront revenue recognition when the license is delivered as well as revenue recognized ratably over the contract period for support and maintenance based on the stand-ready nature of these subscription elements. Services comprise consulting services as well as public and private training. Revenue from services is recognized as these services are delivered. The Company generates sales directly through its sales team and through its channel partners. Sales to channel partners are made at a discount and revenues are recorded at this discounted price once all the revenue recognition criteria above are met. To the extent that the Company offers rebates, incentives or joint marketing funds to such channel partners, recorded revenues are reduced by this amount. Channel partners generally receive an order from an end customer prior to placing an order with the Company. Payment from channel partners is not contingent on the partner’s collection from end customers. Contract Balances The timing of revenue recognition may differ from the timing of invoicing to customers. For annual contracts, the Company typically invoices customers at the time of entering into the contract. For multi-year agreements, the Company generally invoices customers on an annual basis prior to each anniversary of the contract start date. The Company records unbilled accounts receivable related to revenue recognized in excess of amounts invoiced as the Company has an unconditional right to invoice and receive payment in the future related to those fulfilled obligations. Contract liabilities consist of deferred revenue which is recognized over the contractual period. Deferred Contract Acquisition Costs Deferred contract acquisition costs represent costs that are incremental to the acquisition of customer contracts, which consist mainly of sales commissions and associated payroll taxes. The Company determines whether costs should be deferred based on sales compensation plans, if the commissions are in fact incremental and would not have occurred absent the customer contract. Sales commissions for renewal of a subscription contract are not considered commensurate with the commissions paid for contracts with new customers and incremental sales to existing customers given the substantive difference in commission rates in proportion to their respective contract values. Commissions paid for contracts with new customers and incremental sales to existing customers are amortized over an estimated period of benefit of five years, while commissions paid for renewal contracts are amortized based on the pattern of the associated revenue recognition over the related contractual renewal period for the pool of renewal contracts. The Company determines the period of benefit for commissions paid for contracts with new customers and incremental sales to existing customers by taking into consideration its initial estimated customer life and the technological life of its software and related significant features. Commissions paid on services are typically amortized in accordance with the associated revenue as the commissions paid on new and renewal services are commensurate with each other. Amortization of deferred contract acquisition costs is recognized in sales and marketing expense in the consolidated statement of operations. The Company periodically reviews the carrying amount of deferred contract acquisition costs to determine whether events or changes in circumstances have occurred that could impact the period of benefit of these deferred costs. Cost of Revenue Cost of revenue consists primarily of costs related to providing subscriptions and services to the Company’s customers, including personnel costs (salaries, bonuses and benefits, and stock-based compensation) and related expenses for customer support and services personnel, as well as cloud infrastructure costs, third-party expenses, depreciation of fixed assets, amortization associated with acquired intangible assets, and allocated overhead. Research and Development Research and development costs are expe |
Organization and Description of
Organization and Description of Business | 12 Months Ended |
Apr. 30, 2024 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Organization and Description of Business | Organization and Description of Business Elastic N.V. (individually and together with its consolidated subsidiaries, “Elastic” or the “Company”) was incorporated under the laws of the Netherlands in 2012. The Company created the Elastic Stack, a powerful set of software products that ingest and store data from any source and in any format, and perform search, analysis, and visualization on that data. Developers build on top of the Elastic Stack to apply the power of search to their data and solve business problems. The Company offers three software solutions built into the Elastic Stack: Search, Observability, and Security. The Elastic Stack and the Company’s solutions are designed to run across hybrid clouds, public or private clouds, and multi-cloud environments. |
Revenue
Revenue | 12 Months Ended |
Apr. 30, 2024 | |
Revenue from Contract with Customer [Abstract] | |
Revenue | Revenue Disaggregation of Revenue The following table presents revenue by category (in thousands): Year Ended April 30, 2024 2023 2022 Amount % of Amount % of Amount % of Elastic Cloud $ 547,520 43 % $ 424,053 40 % $ 298,615 35 % Other subscription 629,086 50 % 560,709 52 % 500,155 58 % Total subscription 1,176,606 93 % 984,762 92 % 798,770 93 % Services 90,715 7 % 84,227 8 % 63,604 7 % Total revenue $ 1,267,321 100 % $ 1,068,989 100 % $ 862,374 100 % Concentration of Credit Risk One customer, a channel partner, accounted for 13% and 12% of net accounts receivable as of April 30, 2024 and April 30, 2023, respectively. The same customer accounted for 11% of total revenue during the year ended April 30, 2024. No customer accounted for 10% or more of the Company’s total revenue for the years ended April 30, 2023 and 2022. Deferred Revenue Unbilled Accounts Receivable Remaining Performance Obligations As of April 30, 2024, the Company had $1.351 billion of remaining performance obligations. As of April 30, 2024, the Company expects to recognize approximately 88% of its remaining performance obligations as revenue over the next 24 months and the remainder thereafter. Deferred Contract Acquisition Costs Amortization expense with respect to deferred contract acquisition costs was $78.5 million, $68.9 million, and $60.7 million for the years ended April 30, 2024, 2023, and 2022, respectively. The Company did not recognize any impairment of deferred contract acquisition costs for the years ended April 30, 2024, 2023, and 2022. |
Fair Value Measurements
Fair Value Measurements | 12 Months Ended |
Apr. 30, 2024 | |
Fair Value Disclosures [Abstract] | |
Fair Value Measurements | Fair Value Measurements Financial Assets The following table summarizes assets that are measured at fair value on a recurring basis as of April 30, 2024 (in thousands): Level 1 Level 2 Level 3 Total Financial Assets: Cash and cash equivalents: Money market funds $ 180,248 $ — $ — $ 180,248 U.S. treasury securities 35,407 — — 35,407 Corporate debt securities — 699 — 699 Total included in cash and cash equivalents 215,655 699 — 216,354 Marketable securities: Certificates of deposit — 42,972 — 42,972 Commercial paper — 43,051 — 43,051 Municipal securities — 27,806 — 27,806 U.S. treasury securities 112,471 — — 112,471 International treasuries — 12,642 — 12,642 Corporate debt securities — 269,168 — 269,168 U.S. agency bonds — 35,892 — 35,892 Total marketable securities 112,471 431,531 — 544,002 Mutual fund investments (1) 461 — — 461 Total financial assets $ 328,587 $ 432,230 $ — $ 760,817 (1) Mutual fund investments are held in an irrevocable rabbi trust for payment obligations to non-qualified deferred compensation plan participants. The investments are recorded as part of other assets in the Company’s consolidated balance sheets. The following table summarizes assets that are measured at fair value on a recurring basis as of April 30, 2023 (in thousands): Level 1 Level 2 Level 3 Total Financial Assets: Cash and cash equivalents: Money market funds $ 194,261 $ — $ — $ 194,261 U.S. agency securities — 27,406 — 27,406 Certificates of deposit — 21,750 — 21,750 Commercial paper — 60,750 — 60,750 Total included in cash and cash equivalents 194,261 109,906 — 304,167 Marketable securities: Certificates of deposit — 31,645 — 31,645 Commercial paper — 33,735 — 33,735 U.S. treasury securities 47,627 — — 47,627 Corporate debt securities — 118,228 — 118,228 U.S. agency bonds — 39,806 — 39,806 Total marketable securities 47,627 223,414 — 271,041 Total financial assets $ 241,888 $ 333,320 $ — $ 575,208 Interest income from the Company’s cash, cash equivalents and marketable securities was $28.1 million, $17.7 million, and $0.2 million for the years ended April 30, 2024, 2023, and 2022, respectively, and is included in other income (expense), net in the consolidated statements of operations. As of April 30, 2024 and April 30, 2023, gross unrealized gains and losses on the marketable securities were insignificant. The fluctuations in market interest rates impacted the unrealized losses or gains on these securities. The fair value of available-for-sale securities, by remaining contractual maturity, are as follows (in thousands): As of As of Due within 1 year $ 298,876 $ 168,264 Due between 1 year and 3 years 245,126 102,777 Total marketable securities $ 544,002 $ 271,041 Financial Liabilities In July 2021, the Company issued $575.0 million aggregate principal amount of 4.125% Senior Notes due July 15, 2029 (the “Senior Notes”) in a private placement. Based on the trading prices of the Senior Notes, the fair value of the Senior Notes as of April 30, 2024 was approximately $511.8 million. While the Senior Notes are recorded at cost, the fair value of the Senior Notes was determined based on quoted prices in markets that are not active; accordingly, the Senior Notes are categorized as Level 2 for purposes of the fair value measurement hierarchy. |
Acquisitions
Acquisitions | 12 Months Ended |
Apr. 30, 2024 | |
Business Combinations [Abstract] | |
Acquisitions | Acquisitions Opster Ltd. On November 30, 2023, the Company acquired 100% of the share capital of Opster Ltd. (“Opster”) for a total purchase consideration of $23.0 million. The purchase consideration includes $3.0 million held back by the Company for indemnity obligations which will be released upon the 18-month anniversary of the acquisition. The acquisition was accounted for as a business combination in accordance with ASC 805, Business Combinations, and, accordingly, the total purchase consideration was allocated to the tangible and intangible assets acquired and liabilities assumed based on their estimated fair values on the acquisition date. The total purchase price allocated to developed technology and goodwill was $6.0 million and $15.9 million, respectively. The fair value assigned to developed technology was determined using the cost to recreate approach. The developed technology asset is being amortized on a straight-line basis over the useful life of 5 years, which approximates the pattern in which the developed technology is utilized. Goodwill resulted primarily from the expectation of enhancing the efficiency and management of the Elastic Stack and is not deductible for income tax purposes. |
Balance Sheet Components
Balance Sheet Components | 12 Months Ended |
Apr. 30, 2024 | |
Balance Sheet Components [Abstract] | |
Balance Sheet Components | Balance Sheet Components Property and Equipment, Net The cost and accumulated depreciation of property and equipment were as follows (in thousands): Useful Life (in years) As of As of Leasehold improvements Lesser of estimated useful life or remaining lease term $ 12,683 $ 10,081 Computer hardware and software 3 3,464 2,220 Furniture and fixtures 3-5 7,395 6,093 Assets under construction 428 1,734 Total property and equipment 23,970 20,128 Less: accumulated depreciation (18,517) (15,036) Property and equipment, net $ 5,453 $ 5,092 Depreciation expense related to property and equipment was $3.5 million, $3.6 million, and $3.9 million for the years ended April 30, 2024, 2023, and 2022, respectively. During the year ended April 30, 2023, the Company recorded asset impairment charges related to the exit from leased office space, which included $1.1 million of furniture, equipment, and leasehold improvements. See Note 16 for further details. Intangible Assets, Net Intangible assets consisted of the following as of April 30, 2024 (in thousands): Gross Fair Value Accumulated Amortization Net Book Value Weighted Average Developed technology $ 76,130 $ 55,489 $ 20,641 2.7 Customer relationships 19,598 19,598 — 0.0 Trade names 2,872 2,872 — 0.0 Total $ 98,600 $ 77,959 $ 20,641 2.7 Foreign currency translation adjustment (21) Total $ 20,620 Intangible assets consisted of the following as of April 30, 2023 (in thousands): Gross Fair Value Accumulated Amortization Net Book Value Weighted Average Developed technology $ 70,130 $ 43,136 $ 26,994 2.7 Customer relationships 19,598 17,641 1,957 0.4 Trade names 2,872 2,686 186 0.4 Total $ 92,600 $ 63,463 $ 29,137 2.5 Foreign currency translation adjustment (33) Total $ 29,104 Amortization expense for the intangible assets for the years ended April 30, 2024, 2023, and 2022 was as follows (in thousands): Year Ended April 30, 2024 2023 2022 Cost of revenue – subscription $ 12,353 $ 11,781 $ 10,503 Sales and marketing 2,143 4,887 5,280 Total amortization of acquired intangible assets $ 14,496 $ 16,668 $ 15,783 The expected future amortization expense related to the intangible assets as of April 30, 2024 was as follows (in thousands, by fiscal year): 2025 $ 9,215 2026 6,256 2027 3,244 2028 1,202 2029 703 Total $ 20,620 Goodwill The following table represents the changes to goodwill (in thousands): Carrying Amount Balance as of April 30, 2022 $ 303,906 Foreign currency translation adjustment (264) Balance as of April 30, 2023 303,642 Addition from acquisition 15,854 Foreign currency translation adjustment (116) Balance as of April 30, 2024 $ 319,380 There was no impairment of goodwill during the years ended April 30, 2024, 2023, and 2022. Accrued Expenses and Other Liabilities Accrued expenses and other liabilities consisted of the following (in thousands): As of As of Accrued expenses $ 34,779 $ 24,163 Income taxes payable 10,596 9,738 Value added taxes payable 8,849 9,403 Accrued interest 6,918 6,918 Other 14,150 13,310 Total accrued expenses and other liabilities $ 75,292 $ 63,532 Accrued Compensation and Benefits Accrued compensation and benefits consisted of the following (in thousands): As of As of Accrued vacation $ 35,005 $ 30,026 Accrued commissions 34,339 26,175 Accrued payroll and withholding taxes 9,830 6,586 Other 14,517 13,696 Total accrued compensation and benefits $ 93,691 $ 76,483 Allowance for Credit Losses The following is a summary of the changes in the Company’s allowance for credit losses (in thousands): Year Ended April 30, 2024 2023 2022 Beginning balance $ 3,409 $ 2,700 $ 2,344 Bad debt expense 3,864 2,722 2,980 Accounts written off (2,294) (2,013) (2,624) Ending balance $ 4,979 $ 3,409 $ 2,700 |
Senior Notes
Senior Notes | 12 Months Ended |
Apr. 30, 2024 | |
Debt Disclosure [Abstract] | |
Senior Notes | Senior Notes In July 2021, the Company issued $575.0 million aggregate principal amount of Senior Notes in a private placement. Interest on the Senior Notes is payable semi-annually in arrears on January 15 and July 15 of each year. The Company received net proceeds from the offering of the Senior Notes of $565.7 million after deducting underwriting commissions of $7.2 million and incurred additional issuance costs of $2.1 million. Total debt issuance costs of $9.3 million are being amortized to interest expense using the effective interest method over the term of the Senior Notes. The Company may redeem the Senior Notes, in whole or in part, at any time prior to July 15, 2024 at a price equal to 100% of the principal amount thereof plus a “make-whole” premium and accrued and unpaid interest, if any. The Company may at its election redeem all or a part of the Senior Notes on or after July 15, 2024, on any one or more occasions, at the redemption prices set forth in the indenture governing the Senior Notes (the “Indenture”), plus, in each case, accrued and unpaid interest thereon, if any, to, but excluding, the applicable redemption date. In addition, at any time prior to July 15, 2024, the Company may on any one or more occasions redeem up to 40% of the aggregate principal amount of the Senior Notes outstanding under the Indenture with the net cash proceeds of one or more equity offerings at a redemption price equal to 104.125% of the principal amount of the Senior Notes then outstanding, plus accrued and unpaid interest thereon, if any, to, but excluding, the applicable redemption date. The Company may also at its election redeem the Senior Notes in whole, but not in part, at a price equal to 100% of the principal amount thereof plus accrued and unpaid interest, if any, if certain changes in tax law occur as set forth in the Indenture. If the Company experiences a change of control triggering event (as defined in the Indenture), the Company must offer to repurchase the Senior Notes at a repurchase price equal to 101% of the principal amount of the Senior Notes to be repurchased, plus accrued and unpaid interest, if any, to the repurchase date. The Indenture contains covenants limiting the Company’s ability and the ability of certain subsidiaries to create liens on certain assets to secure debt; grant a subsidiary guarantee of certain debt without also providing a guarantee of the Senior Notes; and consolidate or merge with or into, or sell or otherwise dispose of all or substantially all of its assets to, another person. These covenants are subject to a number of limitations and exceptions. Certain of these covenants will not apply during any period in which the Senior Notes are rated investment grade by Moody’s Investors Service, Inc. and Standard & Poor’s Ratings Services. The net carrying amount of the Senior Notes was as follows (in thousands): As of As of Principal $ 575,000 $ 575,000 Unamortized debt issuance costs (6,388) (7,457) Net carrying amount $ 568,612 $ 567,543 The following table sets forth the interest expense recognized related to the Senior Notes (in thousands): Year Ended April 30, 2024 2023 2022 Contractual interest expense $ 23,719 $ 23,719 $ 19,370 Amortization of debt issuance costs 1,069 1,023 803 Total interest expense related to the Senior Notes $ 24,788 $ 24,742 $ 20,173 |
Commitments and Contingencies
Commitments and Contingencies | 12 Months Ended |
Apr. 30, 2024 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | Commitments and Contingencies Cloud Hosting Commitments The table below reflects the Company’s future minimum purchase obligations relating to non-cancelable agreements for cloud hosting as of April 30, 2024 (in thousands): Years Ending April 30, Purchase Obligations 2025 $ 164,457 2026 157,159 2027 102,936 Total $ 424,552 Actual timing may vary depending on services used and total payments under these capacity commitments may be higher than the total minimum depending on services used. Other Purchase Commitments The Company has future purchase obligations related to general corporate services, subscription software and sales and marketing contracts. As of April 30, 2024, the Company had purchase commitments of $47.8 million related to these contracts, primarily due within the next twelve months. Letters of Credit The Company had a total of $2.3 million in letters of credit outstanding in favor of certain landlords for office space as of April 30, 2024. Legal Matters From time to time, the Company has become involved in claims and other legal matters arising in the ordinary course of business. The Company investigates these claims as they arise. Although claims are inherently unpredictable, the Company is currently not aware of any matters that, if determined adversely to the Company, would individually or taken together have a material adverse effect on its business, results of operations, financial position or cash flows. The Company accrues estimates for resolution of legal and other contingencies when losses are probable and reasonably estimable. Indemnification The Company enters into indemnification provisions under its agreements with other companies in the ordinary course of business, including business partners, landlords, contractors and parties performing its research and development. Pursuant to these arrangements, the Company agrees to indemnify, hold harmless, and reimburse the indemnified party for certain losses suffered or incurred by the indemnified party as a result of the Company’s activities. The maximum potential amount of future payments the Company could be required to make under these agreements is not determinable. The Company has never incurred costs to defend lawsuits or settle claims related to these indemnification agreements. As a result, the Company believes the fair value of these agreements is not material. The Company maintains commercial general liability insurance and product liability insurance to offset certain of the Company’s potential liabilities under these indemnification provisions. In addition, the Company indemnifies its officers, directors and certain key employees against certain liabilities that may arise as a result of their affiliation with the Company. To date, there have been no claims under any indemnification provisions. Gain Contingencies From time to time the Company may realize a gain contingency, although recognition will not occur until cash is received or the gain is deemed as realizable. In connection with a favorable settlement of a legal claim, the Company recognized a gain of $0.4 million and $10.4 million included in other income (expense), net in the accompanying consolidated statements of operations for the years ended April 30, 2024 and 2023, respectively. |
Leases
Leases | 12 Months Ended |
Apr. 30, 2024 | |
Leases [Abstract] | |
Leases | Leases The Company’s leases provide for rental of corporate office space under non-cancelable operating lease agreements that expire at various dates through fiscal 2030. The Company does not have any finance leases. Lease Costs Components of lease costs included in the consolidated statements of operations were as follows (in thousands): Year Ended April 30, 2024 2023 2022 Operating lease cost $ 12,114 $ 12,411 $ 9,894 Short-term lease cost 1,921 2,217 2,448 Variable lease cost 1,342 726 857 Total lease cost $ 15,377 $ 15,354 $ 13,199 Lease term and discount rate information are summarized as follows: As of Weighted average remaining lease term (in years) 2.7 Weighted average discount rate 5.0 % Future minimum lease payments under non-cancelable operating leases on an undiscounted cash flow basis as of April 30, 2024 were as follows (in thousands, by fiscal year): 2025 $ 13,017 2026 7,543 2027 2,684 2028 2,341 2029 1,022 Thereafter 66 Total minimum lease payments 26,673 Less imputed interest (1,588) Present value of future minimum lease payments 25,085 Less current lease liabilities (12,187) Operating lease liabilities, non-current $ 12,898 Future minimum lease payments as of April 30, 2024 include future cash payments on leases with corresponding right-of-use assets which were written down for impairment due to facilities-related cost optimization actions during the year ended April 30, 2023. During the year ended April 30, 2023, the Company recorded an impairment charge of $5.1 million related to the exit from leased office space. See Note 16 for further details. Subsequent to April 30, 2024, the Company executed an operating lease agreement for an office space with an expected commencement date in the third quarter of fiscal 2025. The lease term is approximately 11 years with undiscounted future minimum lease payments of approximately $12.4 million. |
Ordinary Shares
Ordinary Shares | 12 Months Ended |
Apr. 30, 2024 | |
Equity [Abstract] | |
Ordinary Shares | Ordinary Shares The Company’s authorized ordinary share capital pursuant to its articles of association amounts to 165 million ordinary shares at a par value per ordinary share of €0.01. Each holder of ordinary shares has the right to one vote per ordinary share. The holders of ordinary shares are also entitled to receive dividends whenever funds are legally available and when proposed by the Company’s board of directors and adopted by the general meeting of shareholders, subject to the prior rights of holders of all classes of shares outstanding having priority rights to dividends. No dividends have been declared from the Company’s inception through April 30, 2024. The board of directors has been authorized by the general meeting of shareholders, on the Company’s behalf, to issue the Company’s ordinary shares and grant rights to acquire the Company’s ordinary shares in an amount up to 20% of the issued share capital of the Company as of August 21, 2023. This authorization is valid for a period of 18 months from October 5, 2023. Ordinary Shares Reserved for Issuance The Company has reserved ordinary shares for issuance as follows: As of April 30, 2024 2023 Stock options issued and outstanding 2,640,423 4,038,238 RSUs issued and outstanding (1) 7,076,836 7,494,399 Available for future grants 20,252,732 17,564,133 Available for 2022 ESPP 5,654,835 6,000,000 Total ordinary shares reserved 35,624,826 35,096,770 (1) Includes 116,523 PSUs issued and outstanding as of April 30, 2024. No PSUs were issued or outstanding as of April 30, 2023. Preference Shares The Company’s authorized preference share capital pursuant to its articles of association amounts to 165 million preference shares at a par value per preference share of €0.01. Each holder of preference shares has rights and preferences, including the right to one vote per preference share. As of April 30, 2024, there were no preference shares issued or outstanding. Preference shares in the capital of the Company may currently only be issued pursuant to a resolution adopted by the general meeting of shareholders at the proposal of the board of directors. |
Equity Incentive Plans
Equity Incentive Plans | 12 Months Ended |
Apr. 30, 2024 | |
Share-Based Payment Arrangement [Abstract] | |
Equity Incentive Plans | Equity Incentive Plans 2022 Employee Stock Purchase Plan In August 2022, the Company’s board of directors adopted and, in October 2022, the Company’s shareholders approved the 2022 ESPP. The Company reserved 6.0 million of the Company’s ordinary shares for future purchase and issuance under the 2022 ESPP in January 2023. The 2022 ESPP allows eligible employees to acquire ordinary shares of the Company at a discount at periodic intervals through accumulated payroll deductions. Eligible employees purchase ordinary shares of the Company during a purchase period at 85% of the market value of the Company’s ordinary shares at either the beginning or end of an offering period, whichever is lower. Offering periods under the 2022 ESPP are approximately six months long and begin on each of March 16 or September 16 or the next trading day thereafter. Under the 2022 ESPP, 345,165 ordinary shares were purchased during the year ended April 30, 2024. No ordinary shares were purchased under the 2022 ESPP during the year ended April 30, 2023. Stock-based compensation expense recognized related to the 2022 ESPP was $7.1 million and $0.9 million for the years ended April 30, 2024 and 2023, respectively. The fair value of the 2022 ESPP offerings was estimated on the offering date using the Black-Scholes option pricing model with the following assumptions: Year Ended April 30, 2024 2023 Expected term (in years) 0.5 0.5 Expected stock price volatility 47.3% - 63.3% 64.0% Risk-free interest rate 5.4% - 5.5% 4.9% Dividend yield —% —% 2012 Stock Option Plan In September 2012, the Company’s board of directors adopted and the Company’s shareholders approved the 2012 Stock Option Plan, which was amended and restated in September 2018 and further amended in December 2021 (as amended and restated, the “2012 Plan”). Under the 2012 Plan, the board of directors, the compensation committee, as administrator of the 2012 Plan, and any other duly authorized committee may grant stock options and other equity-based awards, such as restricted stock awards (“RSAs”), RSUs, and PSUs, to eligible employees, directors, and consultants to attract and retain the best available personnel for positions of substantial responsibility, to provide additional incentive to employees, directors and consultants, and to promote the success of the Company’s business. The Company’s board of directors, compensation committee, or other duly authorized committee determines the vesting schedule for all equity-based awards. Stock options and RSUs granted to employees generally vest over four years, subject to the employees’ continued service to the Company. During the year ended April 30, 2024, the Company granted PSUs that vest over three years with a one-year performance period. The Company’s compensation committee may explicitly deviate from the general vesting schedules in its approval of an equity-based award, as it may deem appropriate. Stock options expire ten years after the date of grant. Stock options, RSAs and RSUs (including PSUs) that are canceled under certain conditions become available for future grant or sale under the 2012 Plan unless the 2012 Plan is terminated. The equity awards available for grant were as follows: Year Ended April 30, 2024 2023 Available at beginning of fiscal year 17,564,133 17,647,684 Awards authorized 4,868,347 4,708,746 Options granted — (94,105) Options canceled 104,137 143,656 RSUs granted (1) (3,399,494) (6,105,614) RSUs canceled (2) 1,115,609 1,263,099 Shares withheld for taxes — 667 Available at end of period 20,252,732 17,564,133 (1) Includes 132,960 PSUs granted during the year ended April 30, 2024. No PSUs were granted during the year ended April 30, 2023. (2) Stock Incentive Plans Assumed in Acquisitions In connection with acquisitions completed in prior years, the Company assumed certain unvested stock options that were outstanding on the date of the respective acquisitions. The assumed stock options will continue to be outstanding and will be governed by the provisions of their respective plans and are included in the stock option activity table below. Stock Options The following table summarizes stock option activity: Stock Options Outstanding Number of Stock Options Outstanding Weighted- Average Exercise Price Remaining Contractual Term (in years) Aggregate Intrinsic Value (in thousands) Balance as of April 30, 2022 5,219,124 $ 29.41 6.22 $ 266,021 Stock options granted 94,105 $ 82.24 Stock options exercised (1,127,036) $ 15.55 Stock options canceled (143,656) $ 78.69 Stock options assumed in acquisition canceled (4,299) $ 47.63 Balance as of April 30, 2023 4,038,238 $ 32.74 5.35 $ 134,778 Stock options exercised (1,292,375) $ 16.19 Stock options canceled (104,137) $ 98.35 Stock options assumed in acquisition canceled (1,303) $ 76.12 Balance as of April 30, 2024 2,640,423 $ 38.23 4.67 $ 178,081 Exercisable as of April 30, 2024 2,395,257 $ 32.69 4.40 $ 173,413 Aggregate intrinsic value represents the difference between the exercise price of the stock options to purchase the Company’s ordinary shares and the fair value of the Company’s ordinary shares. The weighted-average grant-date fair value per share of stock options granted was $48.56 for the year ended April 30, 2023. No stock options were granted during the year ended April 30, 2024. As of April 30, 2024, the Company had unrecognized stock-based compensation expense of $13.0 million related to unvested stock options that the Company expects to recognize over a weighted-average period of 1.66 years. RSUs The following table summarizes RSU activity under the 2012 Plan: Number of Awards Weighted-Average Grant Date Fair Value Outstanding and unvested at April 30, 2022 4,717,548 $ 108.44 RSUs granted 6,105,614 $ 60.08 RSUs released (2,065,664) $ 94.01 RSUs canceled (1,263,099) $ 99.51 Outstanding and unvested at April 30, 2023 7,494,399 $ 74.52 RSUs granted (1) 3,399,494 $ 102.23 RSUs released (2,701,448) $ 80.51 RSUs canceled (2) (1,115,609) $ 75.60 Outstanding and unvested at April 30, 2024 7,076,836 $ 85.38 (1) Includes 132,960 PSUs granted during the year ended April 30, 2024. No PSUs were granted during the year ended April 30, 2023. (2) Includes 16,437 PSUs canceled during the year ended April 30, 2024. No PSUs were canceled during the year ended April 30, 2023. During the year ended April 30, 2024, the Company granted 132,960 PSUs subject to performance and service conditions, with a grant-date fair value of $9.1 million, to certain executives. The PSUs become eligible to vest based on the level of the Company’s achievement against a revenue-based performance goal for fiscal 2024. The amount that may be earned ranges from 0% to 200% of the eligible PSUs. Subject to the executives’ continued service to the Company through the applicable vesting date, one-third of the eligible PSUs will vest following the end of fiscal 2024 and, thereafter, one-eighth of the remaining eligible PSUs will vest on a quarterly basis over two years. In the event that an executive’s continuous service to the Company ceases, any associated unvested PSUs will immediately terminate and be forfeited. As of April 30, 2024, the Company had unrecognized stock-based compensation expense of $558.2 million related to RSUs (including PSUs) that the Company expects to recognize over a weighted-average period of 2.79 years. Determination of Fair Value The determination of the fair value of stock-based options on the date of grant using an option pricing model is affected by the fair value of the Company’s ordinary shares, as well as assumptions regarding a number of complex and subjective variables. The Company uses the Black-Scholes option pricing model to calculate the fair value of stock options, which requires the use of assumptions including actual and projected employee stock option exercise behaviors, expected price volatility of the Company’s ordinary shares, the risk-free interest rate, and expected dividends. Fair Value of Ordinary Shares: Subsequent to the Company’s initial public offering (“IPO”) on October 8, 2018, the fair value of the underlying ordinary shares is determined by the closing price, on the date of the grant, of the Company’s ordinary shares, which are traded publicly on the New York Stock Exchange. Prior to the IPO, the fair value of ordinary shares underlying the stock awards had historically been determined by the board of directors, with input from the Company’s management. The board of directors previously determined the fair value of the ordinary shares at the time of grant of the awards by considering a number of objective and subjective factors, including valuations of comparable companies, sales of redeemable convertible preference shares, sales of ordinary shares to unrelated third parties, operating and financial performance, the lack of liquidity of the Company’s ordinary shares, and general and industry-specific economic outlook. Expected Term: The expected term represents the period that options are expected to be outstanding. For option grants that are considered to be “plain vanilla,” the Company determines the expected term using the simplified method. The simplified method deems the term to be the average of the time-to-vesting and the contractual life of the options. Expected Volatility: Since the Company has limited trading history of its ordinary shares, the expected volatility is derived from the average historical stock volatilities of several unrelated public companies within the Company’s industry that the Company considers to be comparable to its own business over a period equivalent to the option’s expected term. Risk-Free Interest Rate: The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for zero-coupon U.S. Treasury notes with maturities approximately equal to the option’s expected term. Dividend Rate: The expected dividend is assumed to be zero as the Company has never paid dividends and has no current plans to do so. The Company’s expected volatility and expected term involve management’s best estimates, both of which impact the fair value of the option calculated under the Black-Scholes option pricing model and, ultimately, the expense that will be recognized over the life of the option. The fair value of stock options granted and assumed was estimated on the date of grant using the Black-Scholes option pricing model with the following assumptions: Year Ended April 30, 2024 2023 2022 Expected term (in years) N/A 6.02 5.52 - 6.08 Expected stock price volatility N/A 60.7% - 62.0% 59.6% - 60.2% Risk-free interest rate N/A 3.1% - 3.4% 1.4% - 1.8% Dividend yield N/A —% —% Stock-Based Compensation Expense Total stock-based compensation expense recognized in the Company’s consolidated statements of operations was as follows (in thousands): Year Ended April 30, 2024 2023 2022 Cost of revenue Subscription $ 8,774 $ 8,308 $ 8,368 Services 12,539 9,435 6,463 Research and development 93,588 80,170 59,911 Sales and marketing 78,069 68,943 45,798 General and administrative 46,167 37,183 20,654 Stock-based compensation expense, net of amounts capitalized 239,137 204,039 141,194 Capitalized stock-based compensation expense — — 188 Total stock-based compensation expense $ 239,137 $ 204,039 $ 141,382 |
Net Earnings (Loss) Per Share A
Net Earnings (Loss) Per Share Attributable to Ordinary Shareholders | 12 Months Ended |
Apr. 30, 2024 | |
Earnings Per Share [Abstract] | |
Net Earnings (Loss) Per Share Attributable to Ordinary Shareholders | Net Earnings (Loss) Per Share Attributable to Ordinary Shareholders The following table sets forth the computation of basic and diluted net earnings (loss) per share attributable to ordinary shareholders (in thousands, except share and per share data): Year Ended April 30, 2024 2023 2022 Numerator: Net income (loss) $ 61,720 $ (236,161) $ (203,848) Denominator: Weighted-average shares used to compute net earnings (loss) per share attributable to ordinary shareholders Basic 99,646,231 95,729,844 92,547,145 Diluted 103,980,132 95,729,844 92,547,145 Net earnings (loss) per share attributable to ordinary shareholders Basic $ 0.62 $ (2.47) $ (2.20) Diluted $ 0.59 $ (2.47) $ (2.20) The following outstanding potentially dilutive ordinary shares were excluded from the computation of diluted net earnings (loss) per share attributable to ordinary shareholders for the periods presented because the impact of including them would have been antidilutive: Year Ended April 30, 2024 2023 2022 Stock options 634,519 4,038,238 5,219,124 RSUs 1,496,213 7,494,399 4,717,548 2022 ESPP 4,010 197,077 — Total 2,134,742 11,729,714 9,936,672 |
Income Taxes
Income Taxes | 12 Months Ended |
Apr. 30, 2024 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | Income Taxes The Company is incorporated in the Netherlands but operates in various countries with differing tax laws and rates. The geographical breakdown of loss before (benefit from) provision for income taxes is summarized as follows (in thousands): Year Ended April 30, 2024 2023 2022 Dutch $ (233,089) $ (283,010) $ (261,097) Foreign 110,333 66,133 63,308 Loss before income taxes $ (122,756) $ (216,877) $ (197,789) The components of the (benefit from) provision for income taxes were as follows (in thousands): Year Ended April 30, 2024 2023 2022 Current: Dutch $ 4,297 $ 2,910 $ 2,187 Foreign 24,558 17,042 6,892 Total current tax expense 28,855 19,952 9,079 Deferred: Dutch 43 (71) (105) Foreign (213,374) (597) (2,915) Total deferred tax income (213,331) (668) (3,020) Total (benefit from) provision for income taxes $ (184,476) $ 19,284 $ 6,059 The Company’s effective tax rate substantially differed from the Dutch statutory tax rate of 25.8% primarily due to the release of the valuation allowance for most of the United States deferred tax assets and waiver of certain deductions subject to the Base Erosion Anti-Abuse Tax (“BEAT”). A reconciliation of income taxes at the statutory income tax rate to the (benefit from) provision for income taxes included in the consolidated statements of operations is as follows (in thousands, except for rates): Year Ended April 30, 2024 2023 2022 Tax Rate Tax Rate Tax Rate Dutch statutory income tax $ (31,671) 25.8 % $ (55,954) 25.8 % $ (49,448) 25.0 % Foreign income taxed at different rates (2,406) 2.0 % (1,305) 0.6 % (2,197) 1.1 % Stock-based compensation (10,296) 8.4 % 5,018 (2.3) % (31,372) 15.9 % Tax credits (10,149) 8.3 % (7,349) 3.4 % (10,834) 5.5 % Change in valuation allowance (186,166) 151.6 % 69,271 (31.9) % 91,841 (46.4) % Intellectual Property (“IP”) migration 7,353 (6.0) % — — % — — % BEAT waiver election 40,141 (32.7) % — — % — — % Foreign-Derived Intangible Income (“FDII”) exclusion (2,328) 1.9 % — — % — — % Executive compensation 4,091 (3.3) % — — % — — % Deferred tax asset revaluation — — % 6 — % (302) 0.2 % Foreign withholding taxes 2,864 (2.3) % 3,201 (1.5) % 1,773 (0.9) % Other 4,091 (3.4) % 6,396 (3.0) % 6,598 (3.5) % (Benefit from) provision for income taxes $ (184,476) 150.3 % $ 19,284 (8.9) % $ 6,059 (3.1) % Deferred Income Taxes Deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the carrying amounts and the tax basis of assets and liabilities. Management assesses whether it is more likely than not that some portion or all of the deferred tax assets will be realized. Deferred tax assets are reduced by a valuation allowance where management has concluded it is more likely than not that the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income. Management makes estimates and judgments about future taxable income based on assumptions that are consistent with the Company’s plans and estimates. Significant components of the Company’s deferred tax assets and liabilities are summarized as follows (in thousands): As of April 30, 2024 2023 Deferred tax assets: Accrued compensation $ 5,324 $ 3,799 Net operating loss carryforward 547,590 533,051 Intangible assets 5,768 — Deferred revenue 8,057 7,690 Stock-based compensation 18,858 13,950 Tax credits 31,373 28,048 Disallowed interest expense 12,380 10,546 Lease liabilities 3,706 4,320 Other 6,657 5,045 Gross deferred tax assets 639,713 606,449 Less valuation allowance (386,882) (575,557) Total deferred tax assets 252,831 30,892 Deferred tax liabilities: Deferred contract acquisition costs (37,005) (27,988) Intangible assets — (1,740) Right of use assets (2,546) (2,862) Gross deferred tax liabilities (39,551) (32,590) Net deferred tax assets (liabilities) $ 213,280 $ (1,698) The valuation allowance for deferred tax assets as of April 30, 2024 and 2023 was $386.9 million and $575.6 million, respectively. As the Company has generated losses since inception in the Netherlands and is anticipated to have cumulative losses for the foreseeable future, management maintains a full valuation allowance against the net deferred tax assets in this jurisdiction. In addition, the United Kingdom jurisdiction is also anticipated to have cumulative losses for the foreseeable future and, as such, a valuation allowance has been established for this jurisdiction. The valuation allowance in the Netherlands and United Kingdom increased by $61.2 million and decreased by $0.2 million, respectively, for the year ended April 30, 2024 and increased by $80.1 million and less than $0.1 million, respectively, for the year ended April 30, 2023. The income tax benefit was primarily due to the release of the valuation allowance for U.S. federal and certain state deferred tax assets of $250.7 million. The Company regularly assesses the need for a valuation allowance against its deferred tax assets. In making that assessment, positive and negative evidence related to the likelihood of realization of the deferred tax assets is considered to determine, based on the weight of available evidence, whether it is more likely than not that some or all of the deferred tax assets will not be realized. As of January 31, 2024, based on all available positive and negative evidence, having demonstrated sustained profitability which is objective and verifiable, and taking into account anticipated future earnings, the Company has concluded that it is more likely than not that the majority of its U.S. federal and certain states’ deferred tax assets will be realizable. The Company continues to maintain a valuation allowance against its California and certain other states’ deferred tax assets due to the uncertainty regarding realizability of these deferred tax assets as they have not yet met the “more likely than not” realization criteria. The valuation allowance in the United States decreased by $250.7 million for the year ended April 30, 2024 due to the valuation allowance release and decreased by $3.6 million for the year ended April 30, 2023. The valuation allowance for the Netherlands deferred tax assets as of April 30, 2024 and 2023 was $344.5 million and $283.3 million, respectively, the valuation allowance for the United States deferred tax assets as of April 30, 2024 and 2023 was $23.0 million and $272.7 million, respectively, and the valuation allowance for the United Kingdom deferred tax assets as of April 30, 2024 and 2023 was $19.4 million and $19.5 million, respectively. To the extent sufficient positive evidence becomes available, the Company may release all or a portion of the valuation allowance in one or more future periods. A release of the valuation allowance, if any, would result in the recognition of certain deferred tax assets and a material income tax benefit for the period in which such release is recorded. As of April 30, 2024, the Company had net operating loss (“NOL”) carryforwards for Netherlands, United States (federal and state, respectively) and United Kingdom income tax purposes of $1.237 billion, $806.9 million, $641.7 million and $78.2 million, respectively, which begin to expire in the years ending April 30, 2037 and April 30, 2025 for the United States (federal and state, respectively), with Netherlands and United Kingdom losses being carried forward indefinitely. The Company also has research and development tax credit carryforwards for United States (federal and state, respectively), Canada, Spain, and France for income tax purposes of $31.7 million, $9.3 million, $1.9 million, $0.8 million, and $0.2 million, respectively, which begin to expire on April 30, 2038, April 30, 2025, April 30, 2042, April 30, 2041, and April 30, 2025, respectively. The deferred tax assets associated with the NOL carryforwards and other tax attributes in the Netherlands and the United Kingdom are subject to a full valuation allowance. Uncertain Tax Positions The calculation of the Company’s tax obligations involves dealing with uncertainties in the application of complex tax laws and regulations. ASC 740, Income Taxes, provides that a tax benefit from an uncertain tax position may be recognized when it is more likely than not that the position will be sustained upon examination, including resolutions of any related appeals or litigation processes, on the basis of the technical merits. The Company has assessed its income tax positions and recorded tax benefits for all years subject to examination, based upon the Company’s evaluation of the facts, circumstances and information available at each period end. Although the Company believes that it has adequately reserved for its uncertain tax positions, the Company can provide no assurance that the final tax outcome of these matters will not be materially different. As the Company continues to grow in size, it will face increased complexity, and the Company’s unrecognized tax benefits may increase in the future. The Company adjusts its reserves when facts and circumstances change, such as the closing of a tax audit or the refinement of an estimate. To the extent that the final tax outcome of these matters is different than the amounts recorded, such differences will affect the provision for income taxes in the period in which such determination is made. The Company had unrecognized tax benefits of $22.7 million as of April 30, 2024, of which none would impact the effective tax rate before consideration of any valuation allowance. The activity within the Company’s unrecognized tax benefits is summarized as follows (in thousands): As of April 30, 2024 2023 2022 Balance as of beginning of year $ 18,157 $ 16,622 $ 13,656 Increase (decrease) related to tax positions taken in prior periods 1,201 (1,050) (1,029) Increase related to tax positions taken in the current period 3,333 2,585 3,995 Balance as of end of year $ 22,691 $ 18,157 $ 16,622 Approximately $1.2 million of the increase for the year ended April 30, 2024 for tax positions taken in prior periods is due to the filing of tax returns during the fiscal year. Approximately $3.3 million of the increase in tax positions related to the current period is primarily from the research and development tax credits generated for the year ended April 30, 2024. The Company’s policy is to recognize penalties and interest accrued on any unrecognized tax benefits as a component of income tax expense. The Company recognized interest and penalties of $0.2 million for both of the years ended April 30, 2024 and 2023, and $0.3 million for the year ended April 30, 2022. The amount of accrued interest and penalties recorded on the consolidated balance sheet as of April 30, 2024 and 2023 was $0.4 million and $0.2 million, respectively. The Company is subject to periodic examination of income tax returns by various domestic and international tax authorities. During the year ended April 30, 2024, the Company was subject to new audits by various tax authorities. The Company does not anticipate any significant increases or decreases in its uncertain tax positions within the next twelve months. The Company files tax returns in multiple jurisdictions, including the Netherlands and United States. The Company’s tax filings for fiscal years starting with the year ended April 30, 2018 remain open in various tax jurisdictions. Dutch income taxes and non-Dutch withholding taxes associated with the repatriation of earnings or for temporary differences related to investments in non-Dutch subsidiaries, excluding the U.S subsidiaries, have not been provided for, as the Company intends to reinvest the earnings of such subsidiaries indefinitely or the Company has concluded that an immaterial additional tax liability would arise on the distribution of such earnings. Earnings from the Company’s U.S. subsidiaries are treated as being currently repatriated back to the Netherlands, even though no Dutch income taxes or U.S. withholding taxes regarding to such repatriations are recorded due to the Netherlands participation exemption provisions and exemption from withholding taxes under the income tax treaty between the Netherlands and the United States. As of April 30, 2024, there were cumulative earnings of $212.2 million from the non-U.S. subsidiaries. If such earnings were to be repatriated, they would be exempt from taxation in the Netherlands and the amount of dividend withholding taxes from such foreign jurisdictions would be $4.4 million, due to the various income tax treaties between the Netherlands and the respective foreign jurisdictions. |
Employee Benefit Plans
Employee Benefit Plans | 12 Months Ended |
Apr. 30, 2024 | |
Retirement Benefits [Abstract] | |
Employee Benefit Plans | Employee Benefit Plans The Company has a defined-contribution plan in the United States intended to qualify under Section 401 of the Internal Revenue Code (the “401(k) Plan”). The Company has contracted with a third-party provider to act as a custodian and trustee, and to process and maintain the records of participant data. Substantially all the expenses incurred for administering the 401(k) Plan are paid by the Company. The 401(k) Plan covers substantially all U.S. employees who meet minimum age and service requirements and allows participants to defer a portion of their annual compensation on a pre-tax basis. The Company makes contributions to the 401(k) Plan of up to 6% of the participating employee’s W-2 earnings and wages. The Company recorded $18.4 million, $17.9 million, and $15.2 million of expense for the years ended April 30, 2024, 2023, and 2022, respectively related to the 401(k) Plan. |
Segment Information
Segment Information | 12 Months Ended |
Apr. 30, 2024 | |
Segment Reporting [Abstract] | |
Segment Information | Segment Information The following table summarizes the Company’s total revenue by geographic area based on the location of customers (in thousands): Year Ended April 30, 2024 2023 2022 United States $ 730,488 $ 626,688 $ 481,589 Rest of world 536,833 442,301 380,785 Total revenue $ 1,267,321 $ 1,068,989 $ 862,374 Other than the United States, no individual country exceeded 10% or more of total revenue during the periods presented. The following table presents the Company’s long-lived assets, including property and equipment, net, and operating lease right-of-use assets, by geographic region (in thousands): As of April 30, 2024 2023 United States $ 10,571 $ 13,476 The Netherlands 3,716 4,597 United Kingdom 3,470 2,797 Rest of world 8,202 4,219 Total long-lived assets $ 25,959 $ 25,089 |
Restructuring and Other Related
Restructuring and Other Related Charges | 12 Months Ended |
Apr. 30, 2024 | |
Restructuring and Related Activities [Abstract] | |
Restructuring and Other Related Charges | Restructuring and Other Related Charges During the three months ended April 30, 2024, the Company initiated a plan to realign business and strategic priorities which resulted in a reduction of the Company’s workforce. In connection with this plan, the Company incurred charges of $4.2 million primarily consisting of employee-related severance and termination benefits during the year ended April 30, 2024. The execution of this plan is expected to be substantially completed during the first quarter of fiscal 2025. The following table presents activity related to the liability, which is recorded in accrued compensation and employee benefits in the consolidated balance sheet, for restructuring-related employee severance and benefits for the year ended April 30, 2024 (in thousands): Year Ended April 30, 2024 Beginning balance $ — Incurred during the period 4,217 Paid during the period (589) Foreign currency translation adjustment (2) Ending balance $ 3,626 On November 30, 2022, the Company announced and began implementing a plan to align its investments more closely with its strategic priorities by reducing the Company’s workforce by approximately 13% and implementing certain facilities-related cost optimization actions. In connection with this restructuring plan, the Company recorded employee-related severance and other termination benefits of $0.8 million and $23.3 million during the years ended April 30, 2024 and 2023, respectively. The Company also recorded facilities-related charges of $6.2 million during the year ended April 30, 2023. The facilities-related charges included impairment of operating lease right-of-use assets and the associated furniture, equipment, and leasehold improvements of $5.1 million and $1.1 million, respectively, for the exited leased office spaces. The execution of this restructuring plan was completed during the first quarter of fiscal 2024. |
Pay vs Performance Disclosure
Pay vs Performance Disclosure - USD ($) $ in Thousands | 12 Months Ended | ||
Apr. 30, 2024 | Apr. 30, 2023 | Apr. 30, 2022 | |
Pay vs Performance Disclosure | |||
Net income (loss) | $ 61,720 | $ (236,161) | $ (203,848) |
Insider Trading Arrangements
Insider Trading Arrangements | 3 Months Ended |
Apr. 30, 2024 | |
Trading Arrangements, by Individual | |
Rule 10b5-1 Arrangement Adopted | false |
Non-Rule 10b5-1 Arrangement Adopted | false |
Rule 10b5-1 Arrangement Terminated | false |
Non-Rule 10b5-1 Arrangement Terminated | false |
Summary of Significant Accoun_2
Summary of Significant Accounting Policies (Policies) | 12 Months Ended |
Apr. 30, 2024 | |
Accounting Policies [Abstract] | |
Basis of Presentation | Basis of Presentation The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and include the financial statements of the Company and its wholly-owned subsidiaries. All intercompany transactions and accounts have been eliminated in consolidation. |
Fiscal Year | Fiscal Year The Company’s fiscal year ends on April 30. References to fiscal 2024, for example, refer to the fiscal year ended April 30, 2024. |
Use of Estimates and Judgments | Use of Estimates and Judgments The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Such estimates and assumptions include, but are not limited to, standalone selling price (“SSP”) for each distinct performance obligation included in customer contracts with multiple performance obligations, the period of benefit for deferred contract acquisition costs, allowance for credit losses, valuation of stock-based compensation, fair value of ordinary shares in periods prior to the Company’s initial public offering, fair value of acquired intangible assets and goodwill, useful lives of acquired intangible assets and property and equipment, whether an arrangement is or contains a lease, discount rate used for operating leases, and valuation allowance for deferred income taxes. The Company bases these estimates on historical and anticipated results, trends and various other assumptions that it believes are reasonable under the circumstances, including assumptions as to future events. Estimates and assumptions about future events and their effects cannot be determined with certainty and therefore require the exercise of judgment. As of the date of issuance of these financial statements, the Company is not aware of any specific event or circumstance that would require the Company to update its estimates, judgments or revise the carrying value of the Company’s assets or liabilities. These estimates may change, as new events occur and additional information is obtained, and are recognized in the consolidated financial statements as soon as they become known. Actual results could differ from those estimates and any such differences may be material to the Company’s financial statements. |
Foreign Currency | Foreign Currency The reporting currency of the Company is the U.S. dollar. The Company determines the functional currency of each subsidiary in accordance with ASC 830, Foreign Currency Matters, based on the currency of the primary economic environment in which each subsidiary operates. Items included in the financial statements of such subsidiaries are measured using that functional currency. The Company periodically re-assesses its operations to determine if previous conclusions are still valid. Changes in functional currencies are applied prospectively if the operations encounter a significant and permanent change. For the subsidiaries where the U.S. dollar is the functional currency, foreign currency denominated monetary assets and liabilities are re-measured into U.S. dollars at current exchange rates and foreign currency denominated nonmonetary assets and liabilities are re-measured into U.S. dollars at historical exchange rates. Gains or losses from foreign currency re-measurement and settlements are included in other income (expense), net in the consolidated statement of operations. For the years ended April 30, 2024, 2023, and 2022, the Company recognized re-measurement losses of $3.4 million, $0.4 million, and $3.6 million, respectively. For subsidiaries where the functional currency is other than the U.S. dollar, the Company uses the period-end exchange rates to translate assets and liabilities, the average monthly exchange rates to translate revenue and expenses, and historical exchange rates to translate shareholders’ equity into U.S. dollars. The Company records translation gains and losses in accumulated other comprehensive loss as a component of shareholders’ equity in the consolidated balance sheet. |
Other Comprehensive Loss | Other Comprehensive Loss The Company’s other comprehensive loss includes net income (loss), unrealized loss on available-for-sale securities, net of taxes, and foreign currency translation adjustments. |
Cash, Cash Equivalents and Restricted Cash | Cash, Cash Equivalents and Restricted Cash The Company considers all highly liquid investments, including money market funds with an original maturity of three months or less at the date of purchase, to be cash equivalents. The carrying amount of the Company’s cash equivalents approximates fair value, due to the short maturities of these instruments. The Company’s restricted cash consists primarily of cash deposits with financial institutions in support of letters of credit in favor of landlords for non-cancelable lease agreements. Cash, cash equivalents, and restricted cash as reported in the Company’s consolidated statements of cash flows includes the aggregate amounts of cash and cash equivalents and the restricted cash as shown on the consolidated balance sheet. Cash, cash equivalents, and restricted cash as reported in the Company’s consolidated statements of cash flows consists of the following (in thousands): As of April 30, 2024 2023 Cash and cash equivalents $ 540,397 $ 644,167 Restricted cash 2,692 2,473 Cash, cash equivalents and restricted cash $ 543,089 $ 646,640 |
Marketable Securities | Marketable Securities The Company’s marketable securities consist of highly liquid investment-grade fixed-income securities. The Company determines the appropriate classification of its investments at the time of purchase and reevaluates such designation at each balance sheet date. The Company has classified and accounted for its marketable securities as available-for-sale debt securities as the Company may sell these securities at any time for use in its current operations or for other purposes, including prior to maturity. As a result, the Company has classified its marketable securities within current assets on the consolidated balance sheets. Available-for-sale debt securities are recorded at fair value each reporting period. Premiums and discounts are amortized or accreted over the life of the related available-for-sale debt security as an adjustment to yield using the effective interest method. Interest income is recognized when earned. Unrealized gains and losses on these marketable securities are reported as a separate component of accumulated other comprehensive loss until realized. Realized gains and losses are determined based on the specific identification method and are reported in other income (expense), net in the consolidated statements of operations. For available-for-debt securities in an unrealized loss position, the Company first assesses whether it intends to sell the security or it is more likely than not that the Company will be required to sell the security before the recovery of its entire amortized cost basis. If either of these criteria is met, the security’s amortized cost basis is written down to fair value through other income (expense), net in the consolidated statements of operations. If neither of these criteria are met, the Company evaluates whether the decline in fair value below amortized cost is due to credit or non-credit related factors. In making this assessment, the Company considers the extent to which fair value is less than amortized cost, any changes to the rating of the security by a rating agency, and any adverse conditions specifically related to the security, among other factors. Credit related unrealized losses are recognized as an allowance for expected credit losses of available-for-sale securities on the consolidated balance sheets with a corresponding charge in other income (expense), net in the consolidated statements of operations. Non-credit related unrealized losses are included in accumulated other comprehensive income (loss). |
Fair Value of Financial Instruments | Fair Value of Financial Instruments The Company follows ASC 820, Fair Value Measurements and Disclosures, with respect to assets and liabilities that are measured at fair value. Under this standard, fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the reporting date. The accounting guidance establishes a three-tiered hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value as follows: • Level 1: Observable inputs, such as unadjusted quoted prices in active markets for identical assets or liabilities at the measurement date. • Level 2: Observable inputs, other than Level 1 prices, such as quoted prices in active markets for similar assets and liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. • Level 3: Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. The Company’s financial instruments consist of cash equivalents, marketable securities, mutual fund investments held in a rabbi trust, accounts receivable, accounts payable, and accrued liabilities. Cash equivalents are stated at amortized cost, which approximates fair value at the balance sheet dates, due to the short period of time to maturity. Marketable securities and mutual fund investments are recorded at fair value. Accounts receivable, accounts payable and accrued liabilities are stated at their carrying value, which approximates fair value due to the short time to the expected receipt or payment date. |
Concentration of Credit Risk | Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk are primarily cash, cash equivalents, restricted cash, marketable securities, and accounts receivable. The primary focus of the Company’s investment strategy is to preserve capital and meet liquidity requirements. The Company maintains its cash accounts with financial institutions where, at times, deposits exceed federal insurance limits. The Company invests its excess cash in highly-rated money market funds and in short-term investments. The Company extends credit to customers in the normal course of business. The Company performs credit analyses and monitors the financial health of its customers to reduce credit risk. Trade accounts receivable are recorded at the invoiced amount and do not bear interest. Management performs ongoing credit evaluations of customers and maintains allowances for potential credit losses on customers’ accounts when deemed necessary. |
Accounts Receivable, Unbilled Accounts Receivable and Allowance for Credit Losses | Accounts Receivable, Unbilled Accounts Receivable and Allowance for Credit Losses Accounts receivable primarily consists of amounts billed currently due from customers. The Company’s accounts receivable are subject to collection risk. Gross accounts receivable are reduced for this risk by an allowance for credit losses. This allowance is for estimated losses resulting from the inability of the Company’s customers to make required payments. The Company determines the need for an allowance for credit losses based upon various factors, including past collection experience, credit quality of the customer, age of the receivable balance, and current economic conditions, as well as specific circumstances arising with individual customers. Accounts receivables are written off against the allowance when management determines a balance is uncollectible and the Company no longer actively pursues collection of the receivable. The Company does not typically offer right of refund in its contracts. The allowance for credit losses reflects the Company’s best estimate of probable losses inherent in the Company’s receivables portfolio. Unbilled accounts receivable represents amounts for which the Company has recognized revenue, pursuant to the Company’s revenue recognition policy, for fulfilled obligations, but not yet billed. |
Capitalized Software Development and Implementation Costs | Capitalized Software Development and Implementation Costs Software development costs for software to be sold, leased, or otherwise marketed are expensed as incurred until the establishment of technological feasibility, at which time those costs are capitalized until the product is available for general release to customers and amortized over the estimated life of the product. Technological feasibility is established upon the completion of a working prototype that has been certified as having no critical bugs and is a release candidate. To date, costs to develop software that is marketed externally have not been capitalized as the current software development process is essentially completed concurrently with the establishment of technological feasibility. As such, all related software development costs are expensed as incurred and included in research and development expense in the consolidated statement of operations. |
Internal Use Software | Costs related to software acquired, developed, or modified solely to meet the Company’s internal requirements, with no substantive plans to market such software at the time of development, and costs related to the development of web-based product are capitalized during the application development stage. Costs incurred during the preliminary planning and evaluation stage of the project and during the post-implementation operational stage are expensed as incurred. Costs incurred during the application development stage of the project are capitalized. The Company also capitalizes qualifying implementation costs incurred in a hosting arrangement that is a service contract. These costs are amortized on a straight-line basis over the expected life of the service contract, including consideration of the reasonably certain renewal periods, and are presented in the same income statement line items as the service for the related hosting arrangement. The Company did not capitalize any costs during the years ended April 30, 2024 and 2023. All previously capitalized costs are recorded in other assets, non-current on the consolidated balance sheet. |
Property and Equipment | Property and Equipment Property and equipment are recorded at cost and depreciated over their estimated useful lives using the straight-line method. Upon retirement or sale, the cost of assets disposed of and the related accumulated depreciation are removed from the financial statements and any resulting gain or loss is reflected within the consolidated statement of operations. There was no material gain or loss incurred as a result of retirement or sale in the periods presented. Repair and maintenance costs are expensed as incurred. |
Leases | Leases Leases arise from contractual obligations that convey the right to control the use of identified property, plant or equipment for a period of time in exchange for consideration. The Company determines whether an arrangement is or contains a lease at inception, based on whether there is an identified asset and whether the Company controls the use of the identified asset throughout the period of use. At the lease commencement date, the Company determines the lease classification between finance and operating and recognizes a right-of-use asset and corresponding lease liability for each lease component. A right-of-use asset represents the Company’s right to use an underlying asset and a lease liability represents the Company’s obligation to make payments during the lease term. The operating lease right-of-use asset also includes any lease payments made and excludes lease incentives. Lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. The Company accounts for lease components and non-lease components as a single lease component. Leases with an initial term of twelve months or less are classified as short-term leases and therefore are not recognized on the consolidated balance sheets and are expensed on a straight-line basis within the consolidated statement of operations. The lease liability is initially measured as the present value of the remaining lease payments over the lease term. The discount rate used to determine the present value is the Company’s incremental borrowing rate unless the interest rate implicit in the lease is readily determinable. The Company estimates its incremental borrowing rate based on the information available at lease commencement date for borrowings with a similar term. The right-of-use asset is initially measured as the present value of the lease payments, adjusted for initial direct costs, prepaid lease payments to lessors and lease incentives. |
Acquisitions | Acquisitions When the Company acquires a business, the Company allocates the purchase price, which is the sum of the consideration provided and may consist of cash, equity or a combination of the two, in a business combination to the identifiable assets and liabilities of the acquired business at their estimated respective fair values. The Company recognizes and measures contract assets and contract liabilities acquired in a business combination on the acquisition date in accordance with ASC 606, Revenue from Contracts with Customers. The excess of the purchase price over the amount allocated to the identifiable assets and liabilities, if any, is recorded as goodwill. Determining the fair value of assets acquired and liabilities assumed requires management to use significant judgment and estimates, including, but not limited to, the selection of valuation methodologies, estimates of future revenue and cash flows, costs to rebuild developed technology, discount rates and selection of comparable companies. The Company’s estimates of fair value are based upon assumptions believed to be reasonable, but which are inherently uncertain and unpredictable and, as a result, actual results may differ from estimates. During the measurement period, the Company may record adjustments to the assets acquired and liabilities assumed, with the corresponding offset to goodwill. Upon the conclusion of the measurement period, any subsequent adjustments are recorded to other income (expense), net in the consolidated statement of operations. When the Company issues stock-based or cash awards to an acquired company’s shareholders, the Company evaluates whether the awards are consideration or compensation for post-acquisition services. The evaluation includes, among other things, whether the vesting of the awards is contingent on the continued employment of the acquired company’s shareholders beyond the acquisition date. If continued employment is required for vesting, the awards are treated as compensation for post- acquisition services and recognized as expense over the requisite service period. Acquisition-related transaction costs incurred by the Company are not included as a component of consideration transferred, but are accounted for as an operating expense in the period in which the costs are incurred. The results of businesses acquired in a business combination are included in the Company’s consolidated financial statements from the date of acquisition. |
Goodwill | Goodwill Goodwill represents the excess of the purchase price over the fair value of net assets acquired in business combinations accounted for using the acquisition method for accounting and is not amortized. The Company tests goodwill for impairment at least annually, in the fourth quarter of each year, or more frequently if events or changes in circumstances indicate that this asset may be impaired. For the purposes of impairment testing, the Company has determined that it has one operating segment and one reporting unit. The Company’s test of goodwill impairment starts with a qualitative assessment to determine whether it is necessary to perform a quantitative goodwill impairment test. If qualitative factors indicate that the fair value of the reporting unit is more likely than not less than its carrying amount, then a quantitative goodwill impairment test is performed. For the quantitative analysis, the Company compares the fair value of its reporting unit to its carrying value. If the estimated fair value exceeds book value, goodwill is considered not to be impaired and no additional steps are necessary. However, if the fair value of the reporting unit is less than book value, then goodwill will be impaired by the amount that the carrying amount exceeds the implied fair value. There was no impairment of goodwill recorded for the years ended April 30, 2024, 2023, and 2022. |
Acquired Intangible Assets | Acquired Intangible Assets Acquired amortizable intangible assets are amortized on a straight-line basis over the estimated useful lives of the assets. Useful life Developed technology 4-5 Customer relationships 4 Trade names 4 |
Impairment of Long-Lived Assets | Impairment of Long-Lived Assets The Company evaluates the recoverability of long-lived assets, including property and equipment and amortizable acquired intangible assets, for possible impairment whenever events or circumstances indicate that the carrying amount of such assets may not be fully recoverable. Such events and changes may include: significant changes in performance relative to expected operating results, significant changes in asset use, significant negative industry or economic trends, and changes in the Company’s business strategy. Recoverability of these assets is measured by a comparison of the carrying amounts to the future undiscounted cash flows the assets are expected to generate. If such review indicates that the carrying amount of long-lived assets is not recoverable, the carrying amount of such assets is reduced to fair value. During the year ended April 30, 2023, the Company recorded asset impairment charges comprising impairment of operating lease right-of-use assets and the associated furniture, equipment, and leasehold improvements of $5.1 million and $1.1 million, respectively, for exited leased office spaces associated with the Company’s restructuring plan. See Note 16 for further details. The Company determined that there were no events or changes in circumstances that indicated that its long-lived assets were impaired during the years ended April 30, 2024 and 2022. In addition to the recoverability assessment, the Company periodically reviews the remaining estimated useful lives of property and equipment and amortizable intangible assets. If the estimated useful life assumption for any asset is changed, the remaining unamortized balance would be depreciated or amortized over the revised estimated useful life, on a prospective basis. |
Revenue Recognition | Revenue Recognition The Company generates revenue primarily from the sale of self-managed subscriptions (which include licenses for proprietary features, support, and maintenance) and from the sale of software-as-a-service (“SaaS”) subscriptions. The Company also generates revenue from services, which consist of consulting and training. Under ASC 606, the Company recognizes revenue when its customer obtains control of promised goods or services in an amount that reflects the consideration that the Company expects to receive in exchange for those goods or services. The Company’s contracts include varying terms and conditions, and identifying and evaluating the impact of these terms and conditions on revenue recognition requires significant judgment. In determining the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its agreements, the Company performs the following steps: (i) identification of the contract with a customer; The Company contracts with its customers through order forms, which in some cases are governed by master sales agreements. The Company determines that it has a contract with a customer when the order form has been approved, each party’s rights regarding the products or services to be transferred can be identified, the payment terms for the services can be identified, the Company has determined the customer has the ability and intent to pay and the contract has commercial substance. The Company applies judgment in determining the customer’s ability and intent to pay, which is based on a variety of factors, including the customer’s historical payment experience or, in the case of a new customer, credit, reputation and financial or other information pertaining to the customer. At contract inception the Company evaluates whether two or more contracts should be combined and accounted for as a single contract and whether the combined or single contract includes more than one performance obligation. The Company has concluded that its contracts with customers generally do not contain warranties that give rise to a separate performance obligation. (ii) identification of the performance obligations in the contract; Performance obligations promised in a contract are identified based on the products and services that will be transferred to the customer that are both capable of being distinct, whereby the customer can benefit from the products or services either on their own or together with other resources that are readily available from third parties or from the Company, and are distinct in the context of the contract, whereby the transfer of the products and services is separately identifiable from other promises in the contract. The Company’s self-managed subscriptions include both a license providing the right to use proprietary features in its software, as well as an obligation to provide support (on both open source and proprietary features) and maintenance. The Company’s SaaS products provide access to hosted software as well as support, which the Company considers to be a single performance obligation. Services-related performance obligations relate to the provision of consulting and training services. These services are distinct from subscriptions and do not result in significant customization of the software. (iii) determination of the transaction price; The transaction price is the total amount of consideration the Company expects to be entitled to in exchange for the subscriptions and services in a contract. Variable consideration is included in the transaction price if, in the Company’s judgment, it is probable that a significant future reversal of cumulative revenue under the contract will not occur. None of the Company’s contracts contain a significant financing component. (iv) allocation of the transaction price to the performance obligations; and If the contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. For contracts that contain multiple performance obligations, the Company allocates the transaction price to each performance obligation based on a relative SSP. The SSP is determined based on the prices at which the Company separately sells these products assuming the majority of these prices fall within a pricing range. In instances where SSP is not directly observable, such as when the Company does not sell the software license separately, the Company derives the SSP using information that may include market conditions and other observable and unobservable inputs which can require significant judgment. There is typically more than one SSP for individual products and services due to the stratification of those products and services by quantity, term of the subscription, sales channel and other circumstances. If one of the performance obligations is outside of the SSP range, the Company allocates the transaction price considering the midpoint of the SSP range. The Company also considers if there are any additional material rights inherent in a contract and, if so, the Company allocates a portion of the transaction price to such rights based on a relative SSP. (v) recognition of revenue when the Company satisfies each performance obligation; Revenue is recognized at the time the related performance obligation is satisfied by transferring the promised product or service to the customer. Revenue for SaaS offerings that relate to a specified amount of services is recognized on a consumption basis as the customers utilize the services. Revenue from SaaS offerings that are stand-ready arrangements is recognized ratably over the contract period as the Company satisfies the performance obligation. The Company’s self-managed subscriptions include both upfront revenue recognition when the license is delivered as well as revenue recognized ratably over the contract period for support and maintenance based on the stand-ready nature of these subscription elements. Services comprise consulting services as well as public and private training. Revenue from services is recognized as these services are delivered. The Company generates sales directly through its sales team and through its channel partners. Sales to channel partners are made at a discount and revenues are recorded at this discounted price once all the revenue recognition criteria above are met. To the extent that the Company offers rebates, incentives or joint marketing funds to such channel partners, recorded revenues are reduced by this amount. Channel partners generally receive an order from an end customer prior to placing an order with the Company. Payment from channel partners is not contingent on the partner’s collection from end customers. |
Contract Balances | Contract Balances The timing of revenue recognition may differ from the timing of invoicing to customers. For annual contracts, the Company typically invoices customers at the time of entering into the contract. For multi-year agreements, the Company generally invoices customers on an annual basis prior to each anniversary of the contract start date. The Company records unbilled accounts receivable related to revenue recognized in excess of amounts invoiced as the Company has an unconditional right to invoice and receive payment in the future related to those fulfilled obligations. Contract liabilities consist of deferred revenue which is recognized over the contractual period. |
Deferred Contract Acquisition Costs | Deferred Contract Acquisition Costs Deferred contract acquisition costs represent costs that are incremental to the acquisition of customer contracts, which consist mainly of sales commissions and associated payroll taxes. The Company determines whether costs should be deferred based on sales compensation plans, if the commissions are in fact incremental and would not have occurred absent the customer contract. Sales commissions for renewal of a subscription contract are not considered commensurate with the commissions paid for contracts with new customers and incremental sales to existing customers given the substantive difference in commission rates in proportion to their respective contract values. Commissions paid for contracts with new customers and incremental sales to existing customers are amortized over an estimated period of benefit of five years, while commissions paid for renewal contracts are amortized based on the pattern of the associated revenue recognition over the related contractual renewal period for the pool of renewal contracts. The Company determines the period of benefit for commissions paid for contracts with new customers and incremental sales to existing customers by taking into consideration its initial estimated customer life and the technological life of its software and related significant features. Commissions paid on services are typically amortized in accordance with the associated revenue as the commissions paid on new and renewal services are commensurate with each other. Amortization of deferred contract acquisition costs is recognized in sales and marketing expense in the consolidated statement of operations. The Company periodically reviews the carrying amount of deferred contract acquisition costs to determine whether events or changes in circumstances have occurred that could impact the period of benefit of these deferred costs. |
Cost of Revenue | Cost of Revenue Cost of revenue consists primarily of costs related to providing subscriptions and services to the Company’s customers, including personnel costs (salaries, bonuses and benefits, and stock-based compensation) and related expenses for customer support and services personnel, as well as cloud infrastructure costs, third-party expenses, depreciation of fixed assets, amortization associated with acquired intangible assets, and allocated overhead. |
Research and Development | Research and Development Research and development costs are expensed as incurred and consist primarily of personnel costs, including salaries, bonuses and benefits, and stock-based compensation. Research and development costs also include depreciation and allocated overhead. |
Advertising | Advertising |
Stock-Based Compensation | Stock-Based Compensation Compensation expense related to stock awards issued to employees and directors, including stock options and restricted stock units (“RSUs”) and performance share units (“PSUs”) is measured at the fair value on the date of the grant and recognized over the requisite service period. The fair value of stock options and purchase rights issued to employees under the 2022 Employee Stock Purchase Plan (“2022 ESPP”) is estimated on the date of the grant using the Black-Scholes option-pricing model. The fair value of RSUs and PSUs is estimated on the date of the grant based on the fair value of the Company’s underlying ordinary shares. Compensation expense for stock options and RSUs is recognized on a straight-line basis over the requisite service period and over the six-month offering period in the case of the 2022 ESPP. Compensation expense relating to PSUs is recognized using the accelerated attribution method over the requisite service period when it is probable that the performance condition will be satisfied. The Company recognizes forfeitures as they occur. |
Debt Issuance Costs | Debt Issuance Costs Costs incurred in connection with the issuance of debt are deferred and amortized as interest expense over the term of the related debt using the effective interest method. To the extent that the debt is outstanding, these amounts are reflected in the consolidated balance sheets as direct deductions from the carrying amount of the outstanding borrowings. |
Net Earnings (Loss) Per Share Attributable to Ordinary Shareholders | Net Earnings (Loss) Per Share Attributable to Ordinary Shareholders The Company calculates basic net earnings (loss) per share by dividing the net income (loss) by the weighted-average number of ordinary shares outstanding during the period, less shares subject to repurchase. Diluted net earnings (loss) per share is computed by giving effect to all potentially dilutive ordinary share equivalents outstanding for the period, including stock options, RSUs, and ESPP shares. |
Treasury Shares | Treasury Shares Ordinary shares of the Company that are repurchased are recorded as treasury shares at cost and are included as a component of shareholders’ equity. As of April 30, 2024 and 2023, the Company had 35,937 treasury shares that were repurchased at an average price of $10.30 per share. |
Segments | Segments Operating segments are defined as components of an entity for which separate financial information is available and that is regularly reviewed by the Chief Operating Decision Maker (“CODM”). The Company’s Chief Executive Officer is its CODM. The Company’s CODM reviews financial information presented on a consolidated basis for the purposes of making operating decisions, allocating resources and evaluating financial performance. As such, the Company has determined that it operates in one operating and one reportable segment. The Company presents financial information about its operating segment and geographical areas in Note 15. |
Income Taxes | Income Taxes The Company is subject to income taxes in the Netherlands and numerous foreign jurisdictions. These foreign jurisdictions may have different statutory rates than the Netherlands. The Company records a (benefit from) provision for income taxes for the anticipated tax consequences of the reported results of operations using the asset and liability method. Under this method, the Company recognizes deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the financial reporting and the tax basis of assets and liabilities, as well as for operating losses and tax credit carryforwards. Deferred tax assets and liabilities are measured using the tax rates that are expected to apply to taxable income for the years in which those tax assets and liabilities are expected to be realized or settled. The Company records a valuation allowance to reduce its deferred tax assets to the net amount that it believes is more likely than not to be realized. The calculation of the Company’s tax obligations involves dealing with uncertainties in the application of complex tax laws and regulations. ASC 740, Income Taxes, provides that a tax benefit from an uncertain tax position may be recognized when it is more likely than not that the position will be sustained upon examination, including resolutions of any related appeals or litigation processes, on the basis of the technical merits. The Company has assessed its income tax positions and recorded tax benefits for all years subject to examination, based upon the Company’s evaluation of the facts, circumstances and information available at each period end. For those tax positions where the Company has determined there is a greater than 50% likelihood that a tax benefit will be sustained, the Company has recorded the largest amount of tax benefit that may potentially be realized upon ultimate settlement with a taxing authority that has full knowledge of all relevant information. For those income tax positions where it is determined there is less than 50% likelihood that a tax benefit will be sustained, no tax benefit has been recognized. Although the Company believes that it has adequately reserved for its uncertain tax positions, the Company can provide no assurance that the final tax outcome of these matters will not be materially different. As the Company expands internationally, it will face increased complexity, and the Company’s unrecognized tax benefits may increase in the future. The Company makes adjustments to its reserves when facts and circumstances change, such as the closing of a tax audit or the refinement of an estimate. To the extent that the final tax outcome of these matters is different than the amounts recorded, such differences will affect the (benefit from) provision for income taxes in the period in which such determination is made. |
Recently Adopted Accounting Pronouncements And New Accounting Pronouncements Not Yet Adopted | Recently Adopted Accounting Pronouncements Acquisitions: In October 2021, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers, improving consistency in accounting for acquired revenue contracts with customers in a business combination by requiring that acquirers apply ASC 606 to recognize contract assets and contract liabilities as if they had originated the contracts. If the acquiree prepared its financial statements in accordance with U.S. GAAP, the resulting acquired contract assets and liabilities should generally be consistent with the acquiree’s financial statements. The Company adopted ASU No. 2021-08 on May 1, 2023. The Company’s adoption of this ASU did not have a material impact on its consolidated financial statements. New Accounting Pronouncements Not Yet Adopted Income Taxes: In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, requiring enhancements and further transparency to certain income tax disclosures. The new guidance requires consistent categories and greater disaggregation of information in the tax rate reconciliation and information about income taxes paid disaggregated by jurisdiction. The guidance becomes effective for the Company for the fiscal year ending April 30, 2026. Early adoption is permitted. Upon adoption, the guidance may be applied prospectively or retrospectively. The Company is currently evaluating the impact of adopting this standard on its consolidated financial statements. Segment Reporting: In November 2023, the FASB issued ASU No. 2023-07, S egment Reporting (Topic 280): Improvements to Reportable Segment Disclosures , which provides updates to qualitative and quantitative reportable segment disclosure requirements, including enhanced disclosures about significant segment expenses and increased interim disclosure requirements, among others. The guidance becomes effective for the Company for fiscal years beginning after April 30, 2024 and interim periods within fiscal years beginning after April 30, 2025. Early adoption is permitted. Upon adoption, the guidance should be applied retrospectively. The Company is currently evaluating the impact of adopting this standard on its consolidated financial statements. |
Summary of Significant Accoun_3
Summary of Significant Accounting Policies (Tables) | 12 Months Ended |
Apr. 30, 2024 | |
Accounting Policies [Abstract] | |
Schedule of Cash, Cash Equivalents and Restricted Cash | Cash, cash equivalents, and restricted cash as reported in the Company’s consolidated statements of cash flows consists of the following (in thousands): As of April 30, 2024 2023 Cash and cash equivalents $ 540,397 $ 644,167 Restricted cash 2,692 2,473 Cash, cash equivalents and restricted cash $ 543,089 $ 646,640 |
Schedule of Acquired Amortizable Intangible Assets Amortized Over Estimated Useful Lives of Assets | Acquired amortizable intangible assets are amortized on a straight-line basis over the estimated useful lives of the assets. Useful life Developed technology 4-5 Customer relationships 4 Trade names 4 |
Revenue and Performance Obligat
Revenue and Performance Obligations (Tables) | 12 Months Ended |
Apr. 30, 2024 | |
Revenue from Contract with Customer [Abstract] | |
Revenue from External Customers by Products and Services | The following table presents revenue by category (in thousands): Year Ended April 30, 2024 2023 2022 Amount % of Amount % of Amount % of Elastic Cloud $ 547,520 43 % $ 424,053 40 % $ 298,615 35 % Other subscription 629,086 50 % 560,709 52 % 500,155 58 % Total subscription 1,176,606 93 % 984,762 92 % 798,770 93 % Services 90,715 7 % 84,227 8 % 63,604 7 % Total revenue $ 1,267,321 100 % $ 1,068,989 100 % $ 862,374 100 % |
Fair Value Measurements (Tables
Fair Value Measurements (Tables) | 12 Months Ended |
Apr. 30, 2024 | |
Fair Value Disclosures [Abstract] | |
Schedule of Assets Measured at Fair Value on Recurring Basis | The following table summarizes assets that are measured at fair value on a recurring basis as of April 30, 2024 (in thousands): Level 1 Level 2 Level 3 Total Financial Assets: Cash and cash equivalents: Money market funds $ 180,248 $ — $ — $ 180,248 U.S. treasury securities 35,407 — — 35,407 Corporate debt securities — 699 — 699 Total included in cash and cash equivalents 215,655 699 — 216,354 Marketable securities: Certificates of deposit — 42,972 — 42,972 Commercial paper — 43,051 — 43,051 Municipal securities — 27,806 — 27,806 U.S. treasury securities 112,471 — — 112,471 International treasuries — 12,642 — 12,642 Corporate debt securities — 269,168 — 269,168 U.S. agency bonds — 35,892 — 35,892 Total marketable securities 112,471 431,531 — 544,002 Mutual fund investments (1) 461 — — 461 Total financial assets $ 328,587 $ 432,230 $ — $ 760,817 (1) Mutual fund investments are held in an irrevocable rabbi trust for payment obligations to non-qualified deferred compensation plan participants. The investments are recorded as part of other assets in the Company’s consolidated balance sheets. The following table summarizes assets that are measured at fair value on a recurring basis as of April 30, 2023 (in thousands): Level 1 Level 2 Level 3 Total Financial Assets: Cash and cash equivalents: Money market funds $ 194,261 $ — $ — $ 194,261 U.S. agency securities — 27,406 — 27,406 Certificates of deposit — 21,750 — 21,750 Commercial paper — 60,750 — 60,750 Total included in cash and cash equivalents 194,261 109,906 — 304,167 Marketable securities: Certificates of deposit — 31,645 — 31,645 Commercial paper — 33,735 — 33,735 U.S. treasury securities 47,627 — — 47,627 Corporate debt securities — 118,228 — 118,228 U.S. agency bonds — 39,806 — 39,806 Total marketable securities 47,627 223,414 — 271,041 Total financial assets $ 241,888 $ 333,320 $ — $ 575,208 The fair value of available-for-sale securities, by remaining contractual maturity, are as follows (in thousands): As of As of Due within 1 year $ 298,876 $ 168,264 Due between 1 year and 3 years 245,126 102,777 Total marketable securities $ 544,002 $ 271,041 |
Balance Sheet Components (Table
Balance Sheet Components (Tables) | 12 Months Ended |
Apr. 30, 2024 | |
Balance Sheet Components [Abstract] | |
Schedule of Cost and Accumulated Depreciation of Property and Equipment | The cost and accumulated depreciation of property and equipment were as follows (in thousands): Useful Life (in years) As of As of Leasehold improvements Lesser of estimated useful life or remaining lease term $ 12,683 $ 10,081 Computer hardware and software 3 3,464 2,220 Furniture and fixtures 3-5 7,395 6,093 Assets under construction 428 1,734 Total property and equipment 23,970 20,128 Less: accumulated depreciation (18,517) (15,036) Property and equipment, net $ 5,453 $ 5,092 |
Schedule of Intangible Assets | Intangible assets consisted of the following as of April 30, 2024 (in thousands): Gross Fair Value Accumulated Amortization Net Book Value Weighted Average Developed technology $ 76,130 $ 55,489 $ 20,641 2.7 Customer relationships 19,598 19,598 — 0.0 Trade names 2,872 2,872 — 0.0 Total $ 98,600 $ 77,959 $ 20,641 2.7 Foreign currency translation adjustment (21) Total $ 20,620 Intangible assets consisted of the following as of April 30, 2023 (in thousands): Gross Fair Value Accumulated Amortization Net Book Value Weighted Average Developed technology $ 70,130 $ 43,136 $ 26,994 2.7 Customer relationships 19,598 17,641 1,957 0.4 Trade names 2,872 2,686 186 0.4 Total $ 92,600 $ 63,463 $ 29,137 2.5 Foreign currency translation adjustment (33) Total $ 29,104 |
Schedule of Amortization Expense for Intangible Assets | Amortization expense for the intangible assets for the years ended April 30, 2024, 2023, and 2022 was as follows (in thousands): Year Ended April 30, 2024 2023 2022 Cost of revenue – subscription $ 12,353 $ 11,781 $ 10,503 Sales and marketing 2,143 4,887 5,280 Total amortization of acquired intangible assets $ 14,496 $ 16,668 $ 15,783 |
Schedule of Expected Future Amortization Expense of Intangible Assets | The expected future amortization expense related to the intangible assets as of April 30, 2024 was as follows (in thousands, by fiscal year): 2025 $ 9,215 2026 6,256 2027 3,244 2028 1,202 2029 703 Total $ 20,620 |
Schedule of Changes to Goodwill | The following table represents the changes to goodwill (in thousands): Carrying Amount Balance as of April 30, 2022 $ 303,906 Foreign currency translation adjustment (264) Balance as of April 30, 2023 303,642 Addition from acquisition 15,854 Foreign currency translation adjustment (116) Balance as of April 30, 2024 $ 319,380 |
Schedule of Accrued Expenses and Other Liabilities | Accrued expenses and other liabilities consisted of the following (in thousands): As of As of Accrued expenses $ 34,779 $ 24,163 Income taxes payable 10,596 9,738 Value added taxes payable 8,849 9,403 Accrued interest 6,918 6,918 Other 14,150 13,310 Total accrued expenses and other liabilities $ 75,292 $ 63,532 |
Schedule of Accrued Compensation and Benefits | Accrued compensation and benefits consisted of the following (in thousands): As of As of Accrued vacation $ 35,005 $ 30,026 Accrued commissions 34,339 26,175 Accrued payroll and withholding taxes 9,830 6,586 Other 14,517 13,696 Total accrued compensation and benefits $ 93,691 $ 76,483 |
Schedule of Unbilled Accounts Receivable, Deferred Contract Acquisition Costs, and Deferred Revenue from Contracts with Customers | The following is a summary of the changes in the Company’s allowance for credit losses (in thousands): Year Ended April 30, 2024 2023 2022 Beginning balance $ 3,409 $ 2,700 $ 2,344 Bad debt expense 3,864 2,722 2,980 Accounts written off (2,294) (2,013) (2,624) Ending balance $ 4,979 $ 3,409 $ 2,700 |
Senior Notes (Tables)
Senior Notes (Tables) | 12 Months Ended |
Apr. 30, 2024 | |
Debt Disclosure [Abstract] | |
Schedule of Long-Term Debt Instruments | The net carrying amount of the Senior Notes was as follows (in thousands): As of As of Principal $ 575,000 $ 575,000 Unamortized debt issuance costs (6,388) (7,457) Net carrying amount $ 568,612 $ 567,543 The following table sets forth the interest expense recognized related to the Senior Notes (in thousands): Year Ended April 30, 2024 2023 2022 Contractual interest expense $ 23,719 $ 23,719 $ 19,370 Amortization of debt issuance costs 1,069 1,023 803 Total interest expense related to the Senior Notes $ 24,788 $ 24,742 $ 20,173 |
Commitment and Contingencies (T
Commitment and Contingencies (Tables) | 12 Months Ended |
Apr. 30, 2024 | |
Commitments and Contingencies Disclosure [Abstract] | |
Schedule of Purchase Obligations | The table below reflects the Company’s future minimum purchase obligations relating to non-cancelable agreements for cloud hosting as of April 30, 2024 (in thousands): Years Ending April 30, Purchase Obligations 2025 $ 164,457 2026 157,159 2027 102,936 Total $ 424,552 |
Leases (Tables)
Leases (Tables) | 12 Months Ended |
Apr. 30, 2024 | |
Leases [Abstract] | |
Components of Lease Costs | Components of lease costs included in the consolidated statements of operations were as follows (in thousands): Year Ended April 30, 2024 2023 2022 Operating lease cost $ 12,114 $ 12,411 $ 9,894 Short-term lease cost 1,921 2,217 2,448 Variable lease cost 1,342 726 857 Total lease cost $ 15,377 $ 15,354 $ 13,199 |
Lease Term and Discount Rate Information | Lease term and discount rate information are summarized as follows: As of Weighted average remaining lease term (in years) 2.7 Weighted average discount rate 5.0 % |
Future Minimum Lease Payments Based on Current Lease Accounting Standard | Future minimum lease payments under non-cancelable operating leases on an undiscounted cash flow basis as of April 30, 2024 were as follows (in thousands, by fiscal year): 2025 $ 13,017 2026 7,543 2027 2,684 2028 2,341 2029 1,022 Thereafter 66 Total minimum lease payments 26,673 Less imputed interest (1,588) Present value of future minimum lease payments 25,085 Less current lease liabilities (12,187) Operating lease liabilities, non-current $ 12,898 |
Ordinary Shares (Tables)
Ordinary Shares (Tables) | 12 Months Ended |
Apr. 30, 2024 | |
Equity [Abstract] | |
Summary of Ordinary Shares Reserved for Issuance | The Company has reserved ordinary shares for issuance as follows: As of April 30, 2024 2023 Stock options issued and outstanding 2,640,423 4,038,238 RSUs issued and outstanding (1) 7,076,836 7,494,399 Available for future grants 20,252,732 17,564,133 Available for 2022 ESPP 5,654,835 6,000,000 Total ordinary shares reserved 35,624,826 35,096,770 (1) Includes 116,523 PSUs issued and outstanding as of April 30, 2024. No PSUs were issued or outstanding as of April 30, 2023. |
Equity Incentive Plans (Tables)
Equity Incentive Plans (Tables) | 12 Months Ended |
Apr. 30, 2024 | |
Share-Based Payment Arrangement [Abstract] | |
Fair Value Measurement Inputs and Valuation Techniques | The fair value of the 2022 ESPP offerings was estimated on the offering date using the Black-Scholes option pricing model with the following assumptions: Year Ended April 30, 2024 2023 Expected term (in years) 0.5 0.5 Expected stock price volatility 47.3% - 63.3% 64.0% Risk-free interest rate 5.4% - 5.5% 4.9% Dividend yield —% —% The fair value of stock options granted and assumed was estimated on the date of grant using the Black-Scholes option pricing model with the following assumptions: Year Ended April 30, 2024 2023 2022 Expected term (in years) N/A 6.02 5.52 - 6.08 Expected stock price volatility N/A 60.7% - 62.0% 59.6% - 60.2% Risk-free interest rate N/A 3.1% - 3.4% 1.4% - 1.8% Dividend yield N/A —% —% |
Summary of Equity Awards Available for Grant | The equity awards available for grant were as follows: Year Ended April 30, 2024 2023 Available at beginning of fiscal year 17,564,133 17,647,684 Awards authorized 4,868,347 4,708,746 Options granted — (94,105) Options canceled 104,137 143,656 RSUs granted (1) (3,399,494) (6,105,614) RSUs canceled (2) 1,115,609 1,263,099 Shares withheld for taxes — 667 Available at end of period 20,252,732 17,564,133 (1) Includes 132,960 PSUs granted during the year ended April 30, 2024. No PSUs were granted during the year ended April 30, 2023. (2) Includes 16,437 PSUs canceled during the year ended April 30, 2024. No PSUs were canceled during the year ended April 30, 2023. |
Summary of Stock Option Activity | The following table summarizes stock option activity: Stock Options Outstanding Number of Stock Options Outstanding Weighted- Average Exercise Price Remaining Contractual Term (in years) Aggregate Intrinsic Value (in thousands) Balance as of April 30, 2022 5,219,124 $ 29.41 6.22 $ 266,021 Stock options granted 94,105 $ 82.24 Stock options exercised (1,127,036) $ 15.55 Stock options canceled (143,656) $ 78.69 Stock options assumed in acquisition canceled (4,299) $ 47.63 Balance as of April 30, 2023 4,038,238 $ 32.74 5.35 $ 134,778 Stock options exercised (1,292,375) $ 16.19 Stock options canceled (104,137) $ 98.35 Stock options assumed in acquisition canceled (1,303) $ 76.12 Balance as of April 30, 2024 2,640,423 $ 38.23 4.67 $ 178,081 Exercisable as of April 30, 2024 2,395,257 $ 32.69 4.40 $ 173,413 |
Summary of RSU Activity | The following table summarizes RSU activity under the 2012 Plan: Number of Awards Weighted-Average Grant Date Fair Value Outstanding and unvested at April 30, 2022 4,717,548 $ 108.44 RSUs granted 6,105,614 $ 60.08 RSUs released (2,065,664) $ 94.01 RSUs canceled (1,263,099) $ 99.51 Outstanding and unvested at April 30, 2023 7,494,399 $ 74.52 RSUs granted (1) 3,399,494 $ 102.23 RSUs released (2,701,448) $ 80.51 RSUs canceled (2) (1,115,609) $ 75.60 Outstanding and unvested at April 30, 2024 7,076,836 $ 85.38 (1) Includes 132,960 PSUs granted during the year ended April 30, 2024. No PSUs were granted during the year ended April 30, 2023. (2) Includes 16,437 PSUs canceled during the year ended April 30, 2024. No PSUs were canceled during the year ended April 30, 2023. |
Summary of Stock-based Compensation Expense Related to Tender Offer Included in Consolidated Statement of Operations | Total stock-based compensation expense recognized in the Company’s consolidated statements of operations was as follows (in thousands): Year Ended April 30, 2024 2023 2022 Cost of revenue Subscription $ 8,774 $ 8,308 $ 8,368 Services 12,539 9,435 6,463 Research and development 93,588 80,170 59,911 Sales and marketing 78,069 68,943 45,798 General and administrative 46,167 37,183 20,654 Stock-based compensation expense, net of amounts capitalized 239,137 204,039 141,194 Capitalized stock-based compensation expense — — 188 Total stock-based compensation expense $ 239,137 $ 204,039 $ 141,382 |
Net Earnings (Loss) Per Share_2
Net Earnings (Loss) Per Share Attributable to Ordinary Shareholders (Tables) | 12 Months Ended |
Apr. 30, 2024 | |
Earnings Per Share [Abstract] | |
Schedule of Computation of Basic and Diluted Net Loss Per Share Attributable to Ordinary Shareholders | The following table sets forth the computation of basic and diluted net earnings (loss) per share attributable to ordinary shareholders (in thousands, except share and per share data): Year Ended April 30, 2024 2023 2022 Numerator: Net income (loss) $ 61,720 $ (236,161) $ (203,848) Denominator: Weighted-average shares used to compute net earnings (loss) per share attributable to ordinary shareholders Basic 99,646,231 95,729,844 92,547,145 Diluted 103,980,132 95,729,844 92,547,145 Net earnings (loss) per share attributable to ordinary shareholders Basic $ 0.62 $ (2.47) $ (2.20) Diluted $ 0.59 $ (2.47) $ (2.20) |
Schedule of Outstanding Potentially Dilutive Ordinary Shares Excluded from Computation of Diluted Net Loss Per Share Attributable to Ordinary Shareholders | The following outstanding potentially dilutive ordinary shares were excluded from the computation of diluted net earnings (loss) per share attributable to ordinary shareholders for the periods presented because the impact of including them would have been antidilutive: Year Ended April 30, 2024 2023 2022 Stock options 634,519 4,038,238 5,219,124 RSUs 1,496,213 7,494,399 4,717,548 2022 ESPP 4,010 197,077 — Total 2,134,742 11,729,714 9,936,672 |
Income Taxes (Tables)
Income Taxes (Tables) | 12 Months Ended |
Apr. 30, 2024 | |
Income Tax Disclosure [Abstract] | |
Summary of Geographical Breakdown of Income (Loss) Before Provision for Income Taxes | The geographical breakdown of loss before (benefit from) provision for income taxes is summarized as follows (in thousands): Year Ended April 30, 2024 2023 2022 Dutch $ (233,089) $ (283,010) $ (261,097) Foreign 110,333 66,133 63,308 Loss before income taxes $ (122,756) $ (216,877) $ (197,789) |
Summary of Provision for (Benefit from) Income Taxes | The components of the (benefit from) provision for income taxes were as follows (in thousands): Year Ended April 30, 2024 2023 2022 Current: Dutch $ 4,297 $ 2,910 $ 2,187 Foreign 24,558 17,042 6,892 Total current tax expense 28,855 19,952 9,079 Deferred: Dutch 43 (71) (105) Foreign (213,374) (597) (2,915) Total deferred tax income (213,331) (668) (3,020) Total (benefit from) provision for income taxes $ (184,476) $ 19,284 $ 6,059 |
Summary of Reconciliation of Income Taxes Statutory Income Tax Rate to Provision for Income Taxes | A reconciliation of income taxes at the statutory income tax rate to the (benefit from) provision for income taxes included in the consolidated statements of operations is as follows (in thousands, except for rates): Year Ended April 30, 2024 2023 2022 Tax Rate Tax Rate Tax Rate Dutch statutory income tax $ (31,671) 25.8 % $ (55,954) 25.8 % $ (49,448) 25.0 % Foreign income taxed at different rates (2,406) 2.0 % (1,305) 0.6 % (2,197) 1.1 % Stock-based compensation (10,296) 8.4 % 5,018 (2.3) % (31,372) 15.9 % Tax credits (10,149) 8.3 % (7,349) 3.4 % (10,834) 5.5 % Change in valuation allowance (186,166) 151.6 % 69,271 (31.9) % 91,841 (46.4) % Intellectual Property (“IP”) migration 7,353 (6.0) % — — % — — % BEAT waiver election 40,141 (32.7) % — — % — — % Foreign-Derived Intangible Income (“FDII”) exclusion (2,328) 1.9 % — — % — — % Executive compensation 4,091 (3.3) % — — % — — % Deferred tax asset revaluation — — % 6 — % (302) 0.2 % Foreign withholding taxes 2,864 (2.3) % 3,201 (1.5) % 1,773 (0.9) % Other 4,091 (3.4) % 6,396 (3.0) % 6,598 (3.5) % (Benefit from) provision for income taxes $ (184,476) 150.3 % $ 19,284 (8.9) % $ 6,059 (3.1) % |
Summary of Components of Deferred Tax Assets | Significant components of the Company’s deferred tax assets and liabilities are summarized as follows (in thousands): As of April 30, 2024 2023 Deferred tax assets: Accrued compensation $ 5,324 $ 3,799 Net operating loss carryforward 547,590 533,051 Intangible assets 5,768 — Deferred revenue 8,057 7,690 Stock-based compensation 18,858 13,950 Tax credits 31,373 28,048 Disallowed interest expense 12,380 10,546 Lease liabilities 3,706 4,320 Other 6,657 5,045 Gross deferred tax assets 639,713 606,449 Less valuation allowance (386,882) (575,557) Total deferred tax assets 252,831 30,892 Deferred tax liabilities: Deferred contract acquisition costs (37,005) (27,988) Intangible assets — (1,740) Right of use assets (2,546) (2,862) Gross deferred tax liabilities (39,551) (32,590) Net deferred tax assets (liabilities) $ 213,280 $ (1,698) |
Summary of Unrecognized Gross Tax Benefits | The activity within the Company’s unrecognized tax benefits is summarized as follows (in thousands): As of April 30, 2024 2023 2022 Balance as of beginning of year $ 18,157 $ 16,622 $ 13,656 Increase (decrease) related to tax positions taken in prior periods 1,201 (1,050) (1,029) Increase related to tax positions taken in the current period 3,333 2,585 3,995 Balance as of end of year $ 22,691 $ 18,157 $ 16,622 |
Segment Information (Tables)
Segment Information (Tables) | 12 Months Ended |
Apr. 30, 2024 | |
Segment Reporting [Abstract] | |
Schedule of Revenue by Geographic Area | The following table summarizes the Company’s total revenue by geographic area based on the location of customers (in thousands): Year Ended April 30, 2024 2023 2022 United States $ 730,488 $ 626,688 $ 481,589 Rest of world 536,833 442,301 380,785 Total revenue $ 1,267,321 $ 1,068,989 $ 862,374 |
Schedule of Property and Equipment, Net of Depreciation | The following table presents the Company’s long-lived assets, including property and equipment, net, and operating lease right-of-use assets, by geographic region (in thousands): As of April 30, 2024 2023 United States $ 10,571 $ 13,476 The Netherlands 3,716 4,597 United Kingdom 3,470 2,797 Rest of world 8,202 4,219 Total long-lived assets $ 25,959 $ 25,089 |
Restructuring and Other Relat_2
Restructuring and Other Related Charges (Tables) | 12 Months Ended |
Apr. 30, 2024 | |
Restructuring and Related Activities [Abstract] | |
Restructuring and Related Costs | The following table presents activity related to the liability, which is recorded in accrued compensation and employee benefits in the consolidated balance sheet, for restructuring-related employee severance and benefits for the year ended April 30, 2024 (in thousands): Year Ended April 30, 2024 Beginning balance $ — Incurred during the period 4,217 Paid during the period (589) Foreign currency translation adjustment (2) Ending balance $ 3,626 |
Summary of Significant Accoun_4
Summary of Significant Accounting Policies - Additional Information (Details) | 12 Months Ended | ||
Apr. 30, 2024 USD ($) segment $ / shares shares | Apr. 30, 2023 USD ($) $ / shares shares | Apr. 30, 2022 USD ($) | |
Summary Of Significant Accounting Policies [Line Items] | |||
Foreign currency transaction loss (gain) | $ (1,930,000) | $ 1,386,000 | $ (1,984,000) |
Capitalized costs, additions | $ 0 | 0 | |
Number of operating segments | segment | 1 | ||
Number of reportable segments | segment | 1 | ||
Impairment of goodwill | $ 0 | 0 | 0 |
Impairment charges | $ 0 | ||
Estimated amortization period of sales commissions | 5 years | ||
Advertising costs | $ 26,000,000 | $ 22,400,000 | 19,700,000 |
Treasury stock (in shares) | shares | 35,937 | 35,937 | |
Average treasury stock repurchase price ( in $ / shares) | $ / shares | $ 10.30 | $ 10.30 | |
Minimum | |||
Summary Of Significant Accounting Policies [Line Items] | |||
Percentage of likelihood that a tax benefit will be sustained | 50% | ||
Operating Right-Of-Use Assets | |||
Summary Of Significant Accounting Policies [Line Items] | |||
Impairment charges | $ 5,100,000 | ||
Furniture, Equipment, And Leasehold Improvements | |||
Summary Of Significant Accounting Policies [Line Items] | |||
Impairment charges | 1,100,000 | ||
Other Income (Expense) | |||
Summary Of Significant Accounting Policies [Line Items] | |||
Foreign currency transaction loss (gain) | $ (3,400,000) | $ (400,000) | $ 3,600,000 |
Summary of Significant Accoun_5
Summary of Significant Accounting Policies - Cash, Cash Equivalents, And Restricted Cash (Details) - USD ($) $ in Thousands | Apr. 30, 2024 | Apr. 30, 2023 | Apr. 30, 2022 | Apr. 30, 2021 |
Accounting Policies [Abstract] | ||||
Cash and cash equivalents | $ 540,397 | $ 644,167 | ||
Restricted cash | 2,692 | 2,473 | ||
Cash, cash equivalents and restricted cash | $ 543,089 | $ 646,640 | $ 863,637 | $ 403,708 |
Summary of Significant Accoun_6
Summary of Significant Accounting Policies - Acquired Intangible Assets (Details) | Apr. 30, 2024 |
Customer relationships | |
Finite-Lived Intangible Assets [Line Items] | |
Useful life (in years) | 4 years |
Trade names | |
Finite-Lived Intangible Assets [Line Items] | |
Useful life (in years) | 4 years |
Minimum | Developed technology | |
Finite-Lived Intangible Assets [Line Items] | |
Useful life (in years) | 4 years |
Maximum | Developed technology | |
Finite-Lived Intangible Assets [Line Items] | |
Useful life (in years) | 5 years |
Revenue - Schedule of Revenue b
Revenue - Schedule of Revenue by Category (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Apr. 30, 2024 | Apr. 30, 2023 | Apr. 30, 2022 | |
Disaggregation of Revenue [Line Items] | |||
Total revenue | $ 1,267,321 | $ 1,068,989 | $ 862,374 |
Revenue | Product | |||
Disaggregation of Revenue [Line Items] | |||
% of Total Revenue | 100% | 100% | 100% |
Total subscription | |||
Disaggregation of Revenue [Line Items] | |||
Total revenue | $ 1,176,606 | $ 984,762 | $ 798,770 |
Total subscription | Revenue | Product | |||
Disaggregation of Revenue [Line Items] | |||
% of Total Revenue | 93% | 92% | 93% |
SaaS | |||
Disaggregation of Revenue [Line Items] | |||
Total revenue | $ 547,520 | $ 424,053 | $ 298,615 |
SaaS | Revenue | Product | |||
Disaggregation of Revenue [Line Items] | |||
% of Total Revenue | 43% | 40% | 35% |
Self-managed subscription | |||
Disaggregation of Revenue [Line Items] | |||
Total revenue | $ 629,086 | $ 560,709 | $ 500,155 |
Self-managed subscription | Revenue | Product | |||
Disaggregation of Revenue [Line Items] | |||
% of Total Revenue | 50% | 52% | 58% |
Professional services | |||
Disaggregation of Revenue [Line Items] | |||
Total revenue | $ 90,715 | $ 84,227 | $ 63,604 |
Professional services | Revenue | Product | |||
Disaggregation of Revenue [Line Items] | |||
% of Total Revenue | 7% | 8% | 7% |
Revenue - Additional Informatio
Revenue - Additional Information (Details) $ in Thousands | 12 Months Ended | ||
Apr. 30, 2024 USD ($) | Apr. 30, 2023 USD ($) Customer | Apr. 30, 2022 USD ($) Customer | |
Disaggregation of Revenue [Line Items] | |||
Deferred revenue, revenue recognized | $ 522,800 | $ 430,700 | $ 354,400 |
Revenue, remaining performance obligation, amount | $ 1,351,000 | ||
Revenue, remaining performance obligation, percentage | 88% | ||
Revenue, remaining performance obligation, remaining duration | 24 months | ||
Amortization of deferred contract acquisition costs | $ 78,549 | 68,900 | $ 60,738 |
Contracts with Customers | |||
Disaggregation of Revenue [Line Items] | |||
Unbilled accounts receivable | $ 2,500 | $ 2,200 | |
Net Accounts Receivable | Customer Concentration Risk | |||
Disaggregation of Revenue [Line Items] | |||
Number of customers | Customer | 1 | 1 | |
Net Accounts Receivable | Customer Concentration Risk | Customer One | |||
Disaggregation of Revenue [Line Items] | |||
Concentration risk percentage | 13% | 12% | |
Revenue, Product and Service Benchmark | Customer Concentration Risk | Customer One | |||
Disaggregation of Revenue [Line Items] | |||
Concentration risk percentage | 11% |
Fair Value Measurements - Sched
Fair Value Measurements - Schedule of Assets are Measured at Fair Value on Recurring Basis (Details) - Recurring - USD ($) $ in Thousands | Apr. 30, 2024 | Apr. 30, 2023 |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Financial assets | $ 216,354 | $ 304,167 |
Marketable securities | 544,002 | 271,041 |
Total financial assets | 760,817 | 575,208 |
Money market funds | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities | 42,972 | 31,645 |
Commercial paper | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities | 43,051 | 33,735 |
Municipal securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities | 27,806 | |
U.S. treasury securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities | 112,471 | 47,627 |
International treasuries | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities | 12,642 | |
Corporate debt securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities | 269,168 | 118,228 |
U.S. agency bonds | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities | 35,892 | 39,806 |
Mutual fund investments | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities | 461 | |
Level 1 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Financial assets | 215,655 | 194,261 |
Marketable securities | 112,471 | 47,627 |
Total financial assets | 328,587 | 241,888 |
Level 1 | Money market funds | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities | 0 | 0 |
Level 1 | Commercial paper | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities | 0 | 0 |
Level 1 | Municipal securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities | 0 | |
Level 1 | U.S. treasury securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities | 112,471 | 47,627 |
Level 1 | International treasuries | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities | 0 | |
Level 1 | Corporate debt securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities | 0 | 0 |
Level 1 | U.S. agency bonds | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities | 0 | 0 |
Level 1 | Mutual fund investments | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities | 461 | |
Level 2 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Financial assets | 699 | 109,906 |
Marketable securities | 431,531 | 223,414 |
Total financial assets | 432,230 | 333,320 |
Level 2 | Money market funds | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities | 42,972 | 31,645 |
Level 2 | Commercial paper | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities | 43,051 | 33,735 |
Level 2 | Municipal securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities | 27,806 | |
Level 2 | U.S. treasury securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities | 0 | 0 |
Level 2 | International treasuries | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities | 12,642 | |
Level 2 | Corporate debt securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities | 269,168 | 118,228 |
Level 2 | U.S. agency bonds | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities | 35,892 | 39,806 |
Level 2 | Mutual fund investments | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities | 0 | |
Level 3 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Financial assets | 0 | 0 |
Marketable securities | 0 | 0 |
Total financial assets | 0 | 0 |
Level 3 | Money market funds | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities | 0 | 0 |
Level 3 | Commercial paper | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities | 0 | 0 |
Level 3 | Municipal securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities | 0 | |
Level 3 | U.S. treasury securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities | 0 | 0 |
Level 3 | International treasuries | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities | 0 | |
Level 3 | Corporate debt securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities | 0 | 0 |
Level 3 | U.S. agency bonds | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities | 0 | 0 |
Level 3 | Mutual fund investments | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable securities | 0 | |
Money market funds | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Financial assets | 180,248 | 194,261 |
Money market funds | Level 1 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Financial assets | 180,248 | 194,261 |
Money market funds | Level 2 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Financial assets | 0 | 0 |
Money market funds | Level 3 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Financial assets | 0 | 0 |
U.S. agency bonds | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Financial assets | 27,406 | |
U.S. agency bonds | Level 1 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Financial assets | 0 | |
U.S. agency bonds | Level 2 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Financial assets | 27,406 | |
U.S. agency bonds | Level 3 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Financial assets | 0 | |
Certificates of deposit | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Financial assets | 21,750 | |
Certificates of deposit | Level 1 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Financial assets | 0 | |
Certificates of deposit | Level 2 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Financial assets | 21,750 | |
Certificates of deposit | Level 3 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Financial assets | 0 | |
Commercial paper | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Financial assets | 60,750 | |
Commercial paper | Level 1 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Financial assets | 0 | |
Commercial paper | Level 2 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Financial assets | 60,750 | |
Commercial paper | Level 3 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Financial assets | $ 0 | |
U.S. treasury securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Financial assets | 35,407 | |
U.S. treasury securities | Level 1 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Financial assets | 35,407 | |
U.S. treasury securities | Level 2 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Financial assets | 0 | |
U.S. treasury securities | Level 3 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Financial assets | 0 | |
Corporate debt securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Financial assets | 699 | |
Corporate debt securities | Level 1 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Financial assets | 0 | |
Corporate debt securities | Level 2 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Financial assets | 699 | |
Corporate debt securities | Level 3 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Financial assets | $ 0 |
Fair Value Measurements - Addit
Fair Value Measurements - Additional Information (Details) - USD ($) $ in Thousands | 1 Months Ended | 12 Months Ended | ||
Jul. 31, 2021 | Apr. 30, 2024 | Apr. 30, 2023 | Apr. 30, 2022 | |
Fair Value Disclosures [Abstract] | ||||
Interest income | $ 28,100 | $ 17,700 | $ 200 | |
Proceeds from the issuance of debt | $ 575,000 | 0 | $ 0 | $ 575,000 |
Debt instrument, interest rate (in percent) | 4.125% | |||
Fair value of senior notes | $ 511,800 |
Fair Value Measurements - Fair
Fair Value Measurements - Fair Value by Maturity Date (Details) - USD ($) $ in Thousands | Apr. 30, 2024 | Apr. 30, 2023 |
Fair Value Disclosures [Abstract] | ||
Due within 1 year | $ 298,876 | $ 168,264 |
Due between 1 year and 3 years | 245,126 | 102,777 |
Total marketable securities | $ 544,002 | $ 271,041 |
Acquisitions - Additional Infor
Acquisitions - Additional Information (Details) - USD ($) $ in Thousands | 12 Months Ended | |||
Nov. 30, 2023 | Apr. 30, 2024 | Apr. 30, 2023 | Apr. 30, 2022 | |
Business Acquisition [Line Items] | ||||
Goodwill | $ 319,380 | $ 303,642 | $ 303,906 | |
Acquired identifiable intangible assets amortization period | 2 years 8 months 12 days | 2 years 6 months | ||
Developed technology | ||||
Business Acquisition [Line Items] | ||||
Acquired identifiable intangible assets amortization period | 2 years 8 months 12 days | 2 years 8 months 12 days | ||
Opster | ||||
Business Acquisition [Line Items] | ||||
Share capital acquired in business combination (in percentage) | 100% | |||
Purchase consideration | $ 23,000 | |||
Consideration held back for idemnity obligations | 3,000 | |||
Goodwill | 15,900 | |||
Opster | Developed technology | ||||
Business Acquisition [Line Items] | ||||
Intangible assets acquired | $ 6,000 | |||
Acquired identifiable intangible assets amortization period | 5 years |
Balance Sheet Components - Sche
Balance Sheet Components - Schedule of Cost and Accumulated Depreciation of Property and Equipment (Details) - USD ($) $ in Thousands | Apr. 30, 2024 | Apr. 30, 2023 |
Property, Plant and Equipment [Line Items] | ||
Total property and equipment | $ 23,970 | $ 20,128 |
Less: accumulated depreciation | (18,517) | (15,036) |
Property and equipment, net | 5,453 | 5,092 |
Leasehold improvements | ||
Property, Plant and Equipment [Line Items] | ||
Total property and equipment | $ 12,683 | 10,081 |
Computer hardware and software | ||
Property, Plant and Equipment [Line Items] | ||
Useful Life (in years) | 3 years | |
Total property and equipment | $ 3,464 | 2,220 |
Furniture and fixtures | ||
Property, Plant and Equipment [Line Items] | ||
Total property and equipment | $ 7,395 | 6,093 |
Furniture and fixtures | Minimum | ||
Property, Plant and Equipment [Line Items] | ||
Useful Life (in years) | 3 years | |
Furniture and fixtures | Maximum | ||
Property, Plant and Equipment [Line Items] | ||
Useful Life (in years) | 5 years | |
Assets under construction | ||
Property, Plant and Equipment [Line Items] | ||
Total property and equipment | $ 428 | $ 1,734 |
Balance Sheet Components - Addi
Balance Sheet Components - Additional Information (Details) - USD ($) | 12 Months Ended | ||
Apr. 30, 2024 | Apr. 30, 2023 | Apr. 30, 2022 | |
Balance Sheet Components [Abstract] | |||
Depreciation expense | $ 3,500,000 | $ 3,600,000 | $ 3,900,000 |
Goodwill impairment | 0 | 0 | 0 |
Property, Plant and Equipment [Line Items] | |||
Depreciation expense | 3,500,000 | 3,600,000 | $ 3,900,000 |
Impairment charges | $ 0 | ||
Furniture, Equipment, And Leasehold Improvements | |||
Property, Plant and Equipment [Line Items] | |||
Impairment charges | $ 1,100,000 |
Balance Sheet Components - Sc_2
Balance Sheet Components - Schedule of Intangible Assets (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Apr. 30, 2024 | Apr. 30, 2023 | |
Finite-Lived Intangible Assets [Line Items] | ||
Gross Fair Value | $ 98,600 | $ 92,600 |
Accumulated Amortization | 77,959 | 63,463 |
Net Book Value | $ 20,641 | $ 29,137 |
Weighted Average Remaining Useful Life (in years) | 2 years 8 months 12 days | 2 years 6 months |
Foreign currency translation adjustment | $ (21) | $ (33) |
Total | 20,620 | 29,104 |
Developed technology | ||
Finite-Lived Intangible Assets [Line Items] | ||
Gross Fair Value | 76,130 | 70,130 |
Accumulated Amortization | 55,489 | 43,136 |
Net Book Value | $ 20,641 | $ 26,994 |
Weighted Average Remaining Useful Life (in years) | 2 years 8 months 12 days | 2 years 8 months 12 days |
Customer relationships | ||
Finite-Lived Intangible Assets [Line Items] | ||
Gross Fair Value | $ 19,598 | $ 19,598 |
Accumulated Amortization | 19,598 | 17,641 |
Net Book Value | $ 0 | $ 1,957 |
Weighted Average Remaining Useful Life (in years) | 0 years | 4 months 24 days |
Trade names | ||
Finite-Lived Intangible Assets [Line Items] | ||
Gross Fair Value | $ 2,872 | $ 2,872 |
Accumulated Amortization | 2,872 | 2,686 |
Net Book Value | $ 0 | $ 186 |
Weighted Average Remaining Useful Life (in years) | 0 years | 4 months 24 days |
Balance Sheet Components - Sc_3
Balance Sheet Components - Schedule of Amortization Expense For Intangible Assets (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Apr. 30, 2024 | Apr. 30, 2023 | Apr. 30, 2022 | |
Finite-Lived Intangible Assets [Line Items] | |||
Total amortization of acquired intangible assets | $ 14,496 | $ 16,668 | $ 15,783 |
Cost of revenue | Subscription - self-managed and SaaS | |||
Finite-Lived Intangible Assets [Line Items] | |||
Total amortization of acquired intangible assets | 12,353 | 11,781 | 10,503 |
Sales and marketing | |||
Finite-Lived Intangible Assets [Line Items] | |||
Total amortization of acquired intangible assets | $ 2,143 | $ 4,887 | $ 5,280 |
Balance Sheet Components - Sc_4
Balance Sheet Components - Schedule of Expected Future Amortization Expense of the Intangible Assets (Details) - USD ($) $ in Thousands | Apr. 30, 2024 | Apr. 30, 2023 |
Goodwill and Intangible Assets Disclosure [Abstract] | ||
2025 | $ 9,215 | |
2026 | 6,256 | |
2027 | 3,244 | |
2028 | 1,202 | |
2029 | 703 | |
Total | $ 20,620 | $ 29,104 |
Balance Sheet Components - Sc_5
Balance Sheet Components - Schedule of Changes to Goodwill (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Apr. 30, 2024 | Apr. 30, 2023 | |
Goodwill [Roll Forward] | ||
Beginning balance | $ 303,642 | $ 303,906 |
Foreign currency translation adjustment | (116) | (264) |
Addition from acquisition | 15,854 | |
Ending balance | $ 319,380 | $ 303,642 |
Balance Sheet Components - Sc_6
Balance Sheet Components - Schedule of Accrued Expenses and Other Liabilities (Details) - USD ($) $ in Thousands | Apr. 30, 2024 | Apr. 30, 2023 |
Balance Sheet Components [Abstract] | ||
Accrued expenses | $ 34,779 | $ 24,163 |
Income taxes payable | 10,596 | 9,738 |
Value added taxes payable | 8,849 | 9,403 |
Accrued interest | 6,918 | 6,918 |
Other | 14,150 | 13,310 |
Total accrued expenses and other liabilities | $ 75,292 | $ 63,532 |
Balance Sheet Components - Sc_7
Balance Sheet Components - Schedule of Accrued Compensation and Benefits (Details) - USD ($) $ in Thousands | Apr. 30, 2024 | Apr. 30, 2023 |
Balance Sheet Components [Abstract] | ||
Accrued vacation | $ 35,005 | $ 30,026 |
Accrued commissions | 34,339 | 26,175 |
Accrued payroll and withholding taxes | 9,830 | 6,586 |
Other | 14,517 | 13,696 |
Total accrued compensation and benefits | $ 93,691 | $ 76,483 |
Balance Sheet Components - Liab
Balance Sheet Components - Liabilities (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Apr. 30, 2024 | Apr. 30, 2023 | Apr. 30, 2022 | |
Allowance for Doubtful Accounts Receivable [Roll Forward] | |||
Beginning balance | $ 3,409 | $ 2,700 | $ 2,344 |
Bad debt expense | 3,864 | 2,722 | 2,980 |
Accounts written off | (2,294) | (2,013) | (2,624) |
Ending balance | $ 4,979 | $ 3,409 | $ 2,700 |
Senior Notes - Additional Infor
Senior Notes - Additional Information (Details) - USD ($) | 1 Months Ended | 12 Months Ended | ||
Jul. 31, 2021 | Apr. 30, 2024 | Apr. 30, 2023 | Apr. 30, 2022 | |
Debt Instrument [Line Items] | ||||
Proceeds from the issuance of debt | $ 575,000,000 | $ 0 | $ 0 | $ 575,000,000 |
Long-term debt, net | $ 568,612,000 | $ 567,543,000 | ||
Senior Notes | ||||
Debt Instrument [Line Items] | ||||
Proceeds from the issuance of debt | 575,000,000 | |||
Long-term debt, net | 565,700,000 | |||
underwriting commissions | 7,200,000 | |||
Other issuance cost | 2,100,000 | |||
Debt issuance cost | $ 9,300,000 | |||
Repurchase of debt (as a percent) | 101% | |||
Senior Notes | Debt Instrument, Redemption, Period One | ||||
Debt Instrument [Line Items] | ||||
Redemption price (as a percent) | 100% | |||
Redemption price of principal (as a percent) | 40% | |||
Senior Notes | Debt Instrument, Redemption, Period Two | ||||
Debt Instrument [Line Items] | ||||
Redemption price (as a percent) | 104.125% | |||
Senior Notes | Debt Instrument, Redemption, Period Three | ||||
Debt Instrument [Line Items] | ||||
Redemption price (as a percent) | 100% |
Senior Notes - Carrying Amount
Senior Notes - Carrying Amount of Senior Notes And Interest Expense Recognized (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Apr. 30, 2024 | Apr. 30, 2023 | Apr. 30, 2022 | |
Debt Disclosure [Abstract] | |||
Principal | $ 575,000 | $ 575,000 | |
Unamortized debt issuance costs | (6,388) | (7,457) | |
Long-term debt, net | 568,612 | 567,543 | |
Contractual interest expense | 23,719 | 23,719 | $ 19,370 |
Amortization of debt issuance costs | 1,069 | 1,023 | 803 |
Total interest expense related to the Senior Notes | $ 24,788 | $ 24,742 | $ 20,173 |
Commitments and Contingencies -
Commitments and Contingencies - Additional Information (Details) - USD ($) | 12 Months Ended | |
Apr. 30, 2024 | Apr. 30, 2023 | |
Other Commitments [Line Items] | ||
Letters of credit outstanding amount | $ 2,300,000 | |
Provision for indemnification claims | 0 | |
Proceeds from legal settlements | 400,000 | $ 10,400,000 |
Other Purchase Commitments | ||
Other Commitments [Line Items] | ||
Total purchase obligations | $ 47,800,000 |
Commitments and Contingencies_2
Commitments and Contingencies - Schedule of Purchase Obligations (Details) - Hosting Infrastructure Commitments $ in Thousands | Apr. 30, 2024 USD ($) |
Long-term Purchase Commitment [Line Items] | |
2025 | $ 164,457 |
2026 | 157,159 |
2027 | 102,936 |
Total | $ 424,552 |
Leases - Components of Lease Co
Leases - Components of Lease Costs (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Apr. 30, 2024 | Apr. 30, 2023 | Apr. 30, 2022 | |
Leases [Abstract] | |||
Operating lease cost | $ 12,114 | $ 12,411 | $ 9,894 |
Short-term lease cost | 1,921 | 2,217 | 2,448 |
Variable lease cost | 1,342 | 726 | 857 |
Total lease cost | $ 15,377 | $ 15,354 | $ 13,199 |
Leases - Lease Term and Discoun
Leases - Lease Term and Discount Rate Information (Details) | Apr. 30, 2024 |
Leases [Abstract] | |
Weighted average remaining lease term (in years) | 2 years 8 months 12 days |
Weighted average discount rate | 5% |
Leases - Future Minimum Lease B
Leases - Future Minimum Lease Based on Current Lease Accounting Standard (Details) - USD ($) $ in Thousands | Apr. 30, 2024 | Apr. 30, 2023 |
Leases [Abstract] | ||
2025 | $ 13,017 | |
2026 | 7,543 | |
2027 | 2,684 | |
2028 | 2,341 | |
2029 | 1,022 | |
Thereafter | 66 | |
Total minimum lease payments | 26,673 | |
Less imputed interest | (1,588) | |
Present value of future minimum lease payments | 25,085 | |
Less current lease liabilities | (12,187) | $ (12,749) |
Operating lease liabilities, non-current | $ 12,898 | $ 13,942 |
Leases - Additional Information
Leases - Additional Information (Details) - USD ($) $ in Thousands | 12 Months Ended | |||
Apr. 30, 2024 | Apr. 30, 2023 | Apr. 30, 2022 | Jun. 11, 2024 | |
Property, Plant, and Equipment, Lessor Asset under Operating Lease [Line Items] | ||||
Asset impairment charges | $ 0 | $ 6,242 | $ 0 | |
Undiscounted future minimum lease payments | $ 26,673 | |||
Subsequent Event | ||||
Property, Plant, and Equipment, Lessor Asset under Operating Lease [Line Items] | ||||
Lease term (in years) | 11 years | |||
Undiscounted future minimum lease payments | $ 12,400 | |||
Leased Office Space | ||||
Property, Plant, and Equipment, Lessor Asset under Operating Lease [Line Items] | ||||
Asset impairment charges | $ 5,100 |
Ordinary Shares - Additional In
Ordinary Shares - Additional Information (Details) | 12 Months Ended | |||
Apr. 30, 2024 € / shares | Apr. 30, 2024 USD ($) shares | Apr. 30, 2023 shares | Oct. 10, 2018 shares | |
Class of Stock [Line Items] | ||||
Common Stock, Shares Authorized | 165,000,000 | |||
Ordinary shares, voting rights | one vote per ordinary share | |||
Dividends declared | $ | $ 0 | |||
Convertible Preference Shares | ||||
Class of Stock [Line Items] | ||||
Preference shares, shares authorized (in shares) | 165,000,000 | 165,000,000 | 165,000,000 | |
Preference shares, shares issued (in shares) | 0 | 0 | ||
Preference shares, shares outstanding (in shares) | 0 | 0 | ||
Maximum | ||||
Class of Stock [Line Items] | ||||
Ordinary shares, par value (in € / shares) | € / shares | € 0.01 |
Ordinary Shares - Summary of Or
Ordinary Shares - Summary of Ordinary Shares Reserved for Issuance (Details) - shares | Apr. 30, 2024 | Apr. 30, 2023 |
Class of Stock [Line Items] | ||
Total ordinary shares reserved (in shares) | 35,624,826 | 35,096,770 |
Stock options | ||
Class of Stock [Line Items] | ||
Total ordinary shares reserved (in shares) | 2,640,423 | 4,038,238 |
RSUs | ||
Class of Stock [Line Items] | ||
Total ordinary shares reserved (in shares) | 7,076,836 | 7,494,399 |
Performance Shares | ||
Class of Stock [Line Items] | ||
Total ordinary shares reserved (in shares) | 116,523 | 0 |
2012 Plan | ||
Class of Stock [Line Items] | ||
Total ordinary shares reserved (in shares) | 20,252,732 | 17,564,133 |
Employee Stock Purchase Plan 2022 | ||
Class of Stock [Line Items] | ||
Total ordinary shares reserved (in shares) | 5,654,835 | 6,000,000 |
Equity Incentive Plans - Additi
Equity Incentive Plans - Additional Information (Details) - USD ($) $ / shares in Units, $ in Thousands | 1 Months Ended | 3 Months Ended | 12 Months Ended | ||
Aug. 31, 2022 | Apr. 30, 2024 | Apr. 30, 2024 | Apr. 30, 2023 | Apr. 30, 2022 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Stock-based compensation expense | $ 239,137 | $ 204,039 | $ 141,194 | ||
Weighted-average grant-date fair value of options granted (in dollar per share) | $ 48.56 | ||||
Options granted (in shares) | 0 | 94,105 | |||
Unrecognized stock-based compensation expense related to unvested stock options | $ 13,000 | $ 13,000 | |||
Stock options | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Unrecognized over a weighted-average period (in years) | 1 year 7 months 28 days | ||||
Performance Shares | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Number of Awards, RSUs granted (in shares) | 132,960 | 0 | |||
Grant-date fair value | 9,100 | $ 9,100 | |||
Performance Shares | Minimum | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Earn rate, percent of shares granted | 0% | ||||
Performance Shares | Maximum | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Earn rate, percent of shares granted | 20,000% | ||||
Equity Settled RSUs | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Unrecognized stock-based compensation expense related to unvested stock options | $ 558,200 | $ 558,200 | |||
RSUs | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Unrecognized over a weighted-average period (in years) | 2 years 9 months 14 days | ||||
Number of Awards, RSUs granted (in shares) | 3,399,494 | 6,105,614 | |||
2012 Plan | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Options granted (in shares) | 0 | 94,105 | |||
2012 Plan | RSUs | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Number of Awards, RSUs granted (in shares) | 3,399,494 | 6,105,614 | |||
Employee Stock Purchase Plan 2022 | ESPP | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Value of shares reserved | $ 6,000 | ||||
Purchase price of common stock, percent of market price | 85% | ||||
Purchase period (in months) | 6 months | ||||
Issuance of ordinary shares under employee stock purchase plan (in shares) | 345,165 | 0 | |||
Stock-based compensation expense | $ 7,100 | $ 900 | |||
New Employee | 2012 Plan | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Vesting term (in years) | 4 years |
Equity Incentive Plans - Assump
Equity Incentive Plans - Assumptions Used to Estimated Fair Value of Equity Plans (Details) | 12 Months Ended | ||
Apr. 30, 2024 | Apr. 30, 2023 | Apr. 30, 2022 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Expected stock price volatility, minimum (in percentage) | 60.70% | 59.60% | |
Expected stock price volatility, maximum (in percentage) | 62% | 60.20% | |
Risk-free interest rate, minimum | 3.10% | 1.40% | |
Risk-free interest rate, maximum | 3.40% | 1.80% | |
Dividend yield (in percentage) | 0% | 0% | |
ESPP | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Expected term (in years) | 6 months | 6 months | |
Expected stock price volatility, minimum (in percentage) | 47.30% | ||
Expected stock price volatility, maximum (in percentage) | 63.30% | ||
Expected stock price volatility (in percentage) | 64% | ||
Risk-free interest rate, minimum | 5.40% | ||
Risk-free interest rate, maximum | 5.50% | ||
Risk-free interest rate | 4.90% | ||
Dividend yield (in percentage) | 0% | 0% | |
Minimum | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Expected term (in years) | 6 years 7 days | 5 years 6 months 7 days | |
Maximum | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Expected term (in years) | 6 years 29 days |
Equity Incentive Plans - Summar
Equity Incentive Plans - Summary of Equity Awards Available for Grant (Details) - shares | 12 Months Ended | |
Apr. 30, 2024 | Apr. 30, 2023 | |
Equity Awards, Outstanding [Roll Forward] | ||
Available at beginning of fiscal year (in shares) | 17,564,133 | 17,647,684 |
Awards authorized (in shares) | 4,868,347 | 4,708,746 |
Options granted (in shares) | 0 | (94,105) |
Options cancelled (in shares) | 104,137 | 143,656 |
Available at end of fiscal year (in shares) | 20,252,732 | 17,564,133 |
RSUs | ||
Equity Awards, Outstanding [Roll Forward] | ||
RSUs granted (in shares) | (3,399,494) | (6,105,614) |
RSUs cancelled (in shares) | 1,115,609 | 1,263,099 |
Shares withheld for taxes | 0 | 667 |
Performance Shares | ||
Equity Awards, Outstanding [Roll Forward] | ||
RSUs granted (in shares) | (132,960) | 0 |
RSUs cancelled (in shares) | 16,437 | 0 |
Equity Incentive Plans - Summ_2
Equity Incentive Plans - Summary of Stock Option Activity (Details) - USD ($) $ / shares in Units, $ in Thousands | 12 Months Ended | ||
Apr. 30, 2024 | Apr. 30, 2023 | Apr. 30, 2022 | |
Options, Outstanding Number [Roll Forward] | |||
Options granted (in shares) | 0 | 94,105 | |
2012 Plan | |||
Options, Outstanding Number [Roll Forward] | |||
Beginning balance (in shares) | 4,038,238 | 5,219,124 | |
Stock options assumed in acquisition (in shares) | (1,292,375) | ||
Options granted (in shares) | 0 | 94,105 | |
Stock options exercised (in shares) | (104,137) | (1,127,036) | |
Stock options cancelled (in shares) | (1,303) | (143,656) | |
Stock options assumed in acquisition cancelled (in shares) | (4,299) | ||
Ending balance (in shares) | 2,640,423 | 4,038,238 | 5,219,124 |
Exercisable (in shares) | 2,395,257 | ||
Options Outstanding, Weighted Average Exercise Price [Abstract] | |||
Beginning balance (in dollars per share) | $ 32.74 | $ 29.41 | |
Stock options granted (in dollar per share) | 82.24 | ||
Stock options exercised (in dollars per share) | 16.19 | 15.55 | |
Stock options cancelled (in dollars per share) | 98.35 | 78.69 | |
Stock options assumed in acquisition cancelled (in dollars per share) | 76.12 | 47.63 | |
Ending balance (in dollars per share) | 38.23 | $ 32.74 | $ 29.41 |
Exercisable (in dollars per share) | $ 32.69 | ||
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Remaining Contractual Term Rollforward | |||
Remaining Contractual Term (in years) | 4 years 8 months 1 day | 5 years 4 months 6 days | 6 years 2 months 19 days |
Exercisable, Remaining Contractual Term (in years) | 4 years 4 months 24 days | ||
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Aggregate Intrinsic Value Rollforward | |||
Beginning balance | $ 134,778 | $ 266,021 | |
Ending balance | 178,081 | $ 134,778 | $ 266,021 |
Exercisable | $ 173,413 |
Equity Incentive Plans - Summ_3
Equity Incentive Plans - Summary of RSU Activity (Details) - $ / shares | 12 Months Ended | |
Apr. 30, 2024 | Apr. 30, 2023 | |
RSUs | ||
Non-option Awards, Outstanding Number [Roll Forward] | ||
Number of Awards, RSUs granted (in shares) | 3,399,494 | 6,105,614 |
Number of Awards, RSUs cancelled (in shares) | (1,115,609) | (1,263,099) |
Performance Shares | ||
Non-option Awards, Outstanding Number [Roll Forward] | ||
Number of Awards, RSUs granted (in shares) | 132,960 | 0 |
Number of Awards, RSUs cancelled (in shares) | (16,437) | 0 |
2012 Plan | RSUs | ||
Non-option Awards, Outstanding Number [Roll Forward] | ||
Number of Awards Outstanding and unvested at Beginning of Year ((in shares) | 7,494,399 | 4,717,548 |
Number of Awards, RSUs granted (in shares) | 3,399,494 | 6,105,614 |
Number of Awards, RSUs released (in shares) | (2,701,448) | (2,065,664) |
Number of Awards, RSUs cancelled (in shares) | (1,115,609) | (1,263,099) |
Number of Awards Outstanding and unvested at Year End (in shares) | 7,076,836 | 7,494,399 |
Non-option Awards, Weighted Average Grant Date Fair Value [Roll Forward] | ||
Weighted-Average Grant Date Fair Value, Outstanding and unvested, Beginning of Year (in dollar per share) | $ 74.52 | $ 108.44 |
Weighted-Average Grant Date Fair Value, RSUs granted (in dollar per share) | 102.23 | 60.08 |
Weighted-Average Grant Date Fair Value, RSUs released (in dollar per share) | 80.51 | 94.01 |
Weighted-Average Grant Date Fair Value, RSUs cancelled (in dollar per share) | 75.60 | 99.51 |
Weighted-Average Grant Date Fair Value, Outstanding and unvested, End of Year (in dollar per share) | $ 85.38 | $ 74.52 |
Equity Incentive Plans - Summ_4
Equity Incentive Plans - Summary of Stock-based Compensation Expense Recognized in Consolidated Statements of Operations (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Apr. 30, 2024 | Apr. 30, 2023 | Apr. 30, 2022 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Total stock-based compensation expense | $ 239,137 | $ 204,039 | $ 141,194 |
Capitalized stock-based compensation expense | 0 | 0 | 188 |
Total stock-based compensation expense | 239,137 | 204,039 | 141,382 |
Subscription | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Total stock-based compensation expense | 8,774 | 8,308 | 8,368 |
Services | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Total stock-based compensation expense | 12,539 | 9,435 | 6,463 |
Research and development | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Total stock-based compensation expense | 93,588 | 80,170 | 59,911 |
Sales and marketing | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Total stock-based compensation expense | 78,069 | 68,943 | 45,798 |
General and administrative | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Total stock-based compensation expense | $ 46,167 | $ 37,183 | $ 20,654 |
Net Earnings (Loss) Per Share_3
Net Earnings (Loss) Per Share Attributable to Ordinary Shareholders - Schedule of Computation of Basic and Diluted Net Loss Per Share Attributable to Ordinary Shareholders (Details) - USD ($) $ / shares in Units, $ in Thousands | 12 Months Ended | ||
Apr. 30, 2024 | Apr. 30, 2023 | Apr. 30, 2022 | |
Numerator: | |||
Net income (loss) | $ 61,720 | $ (236,161) | $ (203,848) |
Weighted-average shares used to compute net earnings (loss) per share attributable to ordinary shareholders | |||
Basic (in shares) | 99,646,231 | 95,729,844 | 92,547,145 |
Diluted (in shares) | 103,980,132 | 95,729,844 | 92,547,145 |
Net earnings (loss) per share attributable to ordinary shareholders | |||
Basic (in dollars per share) | $ 0.62 | $ (2.47) | $ (2.20) |
Diluted (in dollars per share) | $ 0.59 | $ (2.47) | $ (2.20) |
Net Earnings (Loss) Per Share_4
Net Earnings (Loss) Per Share Attributable to Ordinary Shareholders - Schedule of Outstanding Potentially Dilutive Ordinary Shares Excluded from Computation of Diluted Net Loss Per Share Attributable to Ordinary Shareholders (Details) - shares | 12 Months Ended | ||
Apr. 30, 2024 | Apr. 30, 2023 | Apr. 30, 2022 | |
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | |||
Antidilutive securities excluded from computation of earnings per share (in shares) | 2,134,742 | 11,729,714 | 9,936,672 |
Stock options | |||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | |||
Antidilutive securities excluded from computation of earnings per share (in shares) | 634,519 | 4,038,238 | 5,219,124 |
RSUs | |||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | |||
Antidilutive securities excluded from computation of earnings per share (in shares) | 1,496,213 | 7,494,399 | 4,717,548 |
ESPP | |||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | |||
Antidilutive securities excluded from computation of earnings per share (in shares) | 4,010 | 197,077 | 0 |
Income Taxes - Summary of Geogr
Income Taxes - Summary of Geographical Breakdown of Income (Loss) Before Provision for Income Taxes (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Apr. 30, 2024 | Apr. 30, 2023 | Apr. 30, 2022 | |
Income Tax Disclosure [Abstract] | |||
Dutch | $ (233,089) | $ (283,010) | $ (261,097) |
Foreign | 110,333 | 66,133 | 63,308 |
Loss before income taxes | $ (122,756) | $ (216,877) | $ (197,789) |
Income Taxes - Summary of Provi
Income Taxes - Summary of Provision for Income Taxes (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Apr. 30, 2024 | Apr. 30, 2023 | Apr. 30, 2022 | |
Current: | |||
Dutch | $ 4,297 | $ 2,910 | $ 2,187 |
Foreign | 24,558 | 17,042 | 6,892 |
Total current tax expense | 28,855 | 19,952 | 9,079 |
Deferred: | |||
Dutch | 43 | (71) | (105) |
Foreign | (213,374) | (597) | (2,915) |
Total deferred tax income | (213,331) | (668) | (3,020) |
Total (benefit from) provision for income taxes | $ (184,476) | $ 19,284 | $ 6,059 |
Income Taxes - Summary of Recon
Income Taxes - Summary of Reconciliation of Income Taxes Statutory Income Tax Rate to Provision for Income Taxes (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Apr. 30, 2024 | Apr. 30, 2023 | Apr. 30, 2022 | |
Income Tax Disclosure [Abstract] | |||
Dutch statutory income tax | $ (31,671) | $ (55,954) | $ (49,448) |
Foreign income taxed at different rates | (2,406) | (1,305) | (2,197) |
Stock-based compensation | (10,296) | 5,018 | (31,372) |
Tax credits | (10,149) | (7,349) | (10,834) |
Change in valuation allowance | (186,166) | 69,271 | 91,841 |
Intellectual Property (“IP”) migration | 7,353 | 0 | 0 |
BEAT waiver election | 40,141 | 0 | 0 |
Foreign-Derived Intangible Income (“FDII”) exclusion | (2,328) | 0 | 0 |
Executive compensation | 4,091 | 0 | 0 |
Deferred tax asset revaluation | 0 | 6 | (302) |
Foreign withholding taxes | 2,864 | 3,201 | 1,773 |
Other | 4,091 | 6,396 | 6,598 |
Total (benefit from) provision for income taxes | $ (184,476) | $ 19,284 | $ 6,059 |
Dutch statutory income tax (in percentage) | 25.80% | 25.80% | 25% |
Foreign income taxed at different rates (in percentage) | 2% | 0.60% | 1.10% |
Stock-based compensation (in percentage) | 8.40% | (2.30%) | 15.90% |
Research and development credits (in percentage) | 8.30% | 3.40% | 5.50% |
Change in valuation allowance (in percentage) | 151.60% | (31.90%) | (46.40%) |
Intellectual Property (“IP”) migration (in percentage) | (6.00%) | 0% | 0% |
BEAT waiver election (in percentage) | (32.70%) | 0% | 0% |
Foreign-Derived Intangible Income (“FDII”) exclusion (in percentage) | 1.90% | 0% | 0% |
Executive compensation (in percentage) | (3.30%) | 0% | 0% |
Deferred tax asset revaluation (in percentage) | 0% | 0% | 0.20% |
Foreign withholding taxes (in percentage) | (2.30%) | (1.50%) | (0.90%) |
Other (in percentage) | (3.40%) | (3.00%) | (3.50%) |
Provision for income taxes (in percentage) | 150.30% | (8.90%) | (3.10%) |
Income Taxes - Summary of Compo
Income Taxes - Summary of Components of Deferred Tax Assets (Details) - USD ($) $ in Thousands | Apr. 30, 2024 | Apr. 30, 2023 |
Deferred tax assets: | ||
Accrued compensation | $ 5,324 | $ 3,799 |
Net operating loss carryforward | 547,590 | 533,051 |
Intangible assets | 5,768 | 0 |
Deferred revenue | 8,057 | 7,690 |
Stock-based compensation | 18,858 | 13,950 |
Tax credits | 31,373 | 28,048 |
Disallowed interest expense | 12,380 | 10,546 |
Lease liabilities | 3,706 | 4,320 |
Other | 6,657 | 5,045 |
Gross deferred tax assets | 639,713 | 606,449 |
Less valuation allowance | (386,882) | (575,557) |
Total deferred tax assets | 252,831 | 30,892 |
Deferred tax liabilities: | ||
Deferred contract acquisition costs | (37,005) | (27,988) |
Intangible assets | 0 | (1,740) |
Right of use assets | (2,546) | (2,862) |
Gross deferred tax liabilities | (39,551) | (32,590) |
Net deferred tax assets (liabilities) | $ 213,280 | $ (1,698) |
Income Taxes - Additional Infor
Income Taxes - Additional Information (Details) - USD ($) | 12 Months Ended | |||
Apr. 30, 2024 | Apr. 30, 2023 | Apr. 30, 2022 | Apr. 30, 2021 | |
Income Tax Contingency [Line Items] | ||||
Valuation allowance | $ (386,882,000) | $ (575,557,000) | ||
Validation allowance, released amount | 250,700,000 | |||
Net operating loss carryforward | 547,590,000 | 533,051,000 | ||
Tax credits | 31,373,000 | 28,048,000 | ||
Unrecognized tax benefits | 22,691,000 | 18,157,000 | $ 16,622,000 | $ 13,656,000 |
Unrecognized tax benefits that would impact the effective tax rate before consideration of valuation allowance | 0 | |||
Increase (decrease) related to tax positions taken in prior periods | 1,201,000 | (1,050,000) | (1,029,000) | |
Increase related to tax positions taken in the current period | 3,333,000 | 2,585,000 | 3,995,000 | |
Accrued interest and penalties, amount | 400,000 | 200,000 | ||
Recognize penalties and interests accrued on unrecognized tax benefits (less than) | 200,000 | $ 300,000 | ||
Dividend withholding tax from foreign jurisdictions | 4,400,000 | |||
Canada Revenue Agency | ||||
Income Tax Contingency [Line Items] | ||||
Tax credits | 1,900,000 | |||
Tax Authority, Spain | ||||
Income Tax Contingency [Line Items] | ||||
Tax credits | 800,000 | |||
Ministry of the Economy, Finance and Industry, France | ||||
Income Tax Contingency [Line Items] | ||||
Tax credits | 200,000 | |||
Dutch | Tax and Customs Administration, Netherlands | ||||
Income Tax Contingency [Line Items] | ||||
Net operating loss carryforward | 1,237,000,000 | |||
U.S. Federal | IRS | ||||
Income Tax Contingency [Line Items] | ||||
Net operating loss carryforward | 806,900,000 | |||
Tax credits | 31,700,000 | |||
U.S. Federal | Her Majesty's Revenue and Customs (HMRC) | ||||
Income Tax Contingency [Line Items] | ||||
Net operating loss carryforward | 78,200,000 | |||
U.S. State Income Tax | ||||
Income Tax Contingency [Line Items] | ||||
Net operating loss carryforward | 641,700,000 | |||
Tax credits | 9,300,000 | |||
The Netherlands | ||||
Income Tax Contingency [Line Items] | ||||
Valuation allowance | (344,500,000) | (283,300,000) | ||
Valuation allowance, net deferred tax assets, jurisdictions increased | 61,200,000 | 80,100,000 | ||
United Kingdom | ||||
Income Tax Contingency [Line Items] | ||||
Valuation allowance | (19,400,000) | (19,500,000) | ||
Valuation allowance, net deferred tax assets, jurisdictions increased | 200,000 | 100,000 | ||
United States | ||||
Income Tax Contingency [Line Items] | ||||
Valuation allowance | (23,000,000) | (272,700,000) | ||
Valuation allowance, net deferred tax assets, jurisdictions increased | 250,700,000 | $ 3,600,000 | ||
Other countries | ||||
Income Tax Contingency [Line Items] | ||||
Cumulative earnings | $ 212,200,000 |
Income Taxes - Summary of Unrec
Income Taxes - Summary of Unrecognized Gross Tax Benefits (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Apr. 30, 2024 | Apr. 30, 2023 | Apr. 30, 2022 | |
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward] | |||
Balance as of beginning of year | $ 18,157 | $ 16,622 | $ 13,656 |
Increase (decrease) related to tax positions taken in prior periods | 1,201 | (1,050) | (1,029) |
Increase related to tax positions taken in the current period | 3,333 | 2,585 | 3,995 |
Balance as of end of year | $ 22,691 | $ 18,157 | $ 16,622 |
Employee Benefit Plans - Additi
Employee Benefit Plans - Additional Information (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Apr. 30, 2024 | Apr. 30, 2023 | Apr. 30, 2022 | |
United States | |||
Defined Contribution Plan Disclosure [Line Items] | |||
Defined contribution expense related to plan | $ 18.4 | $ 17.9 | $ 15.2 |
Other Countries | |||
Defined Contribution Plan Disclosure [Line Items] | |||
Defined contribution expense related to plan | $ 12.7 | $ 9.4 | $ 7.2 |
Maximum | United States | |||
Defined Contribution Plan Disclosure [Line Items] | |||
Percentage of defined contribution to participating employees | 6% |
Segment Information - Schedule
Segment Information - Schedule of Revenue by Geographic Area (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Apr. 30, 2024 | Apr. 30, 2023 | Apr. 30, 2022 | |
Revenues from External Customers and Long-Lived Assets [Line Items] | |||
Total revenue | $ 1,267,321 | $ 1,068,989 | $ 862,374 |
United States | |||
Revenues from External Customers and Long-Lived Assets [Line Items] | |||
Total revenue | 730,488 | 626,688 | 481,589 |
Rest of world | |||
Revenues from External Customers and Long-Lived Assets [Line Items] | |||
Total revenue | $ 536,833 | $ 442,301 | $ 380,785 |
Segment Information - Schedul_2
Segment Information - Schedule of Property and Equipment, Net of Depreciation (Details) - USD ($) $ in Thousands | Apr. 30, 2024 | Apr. 30, 2023 |
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Total long-lived assets | $ 25,959 | $ 25,089 |
United States | ||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Total long-lived assets | 10,571 | 13,476 |
The Netherlands | ||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Total long-lived assets | 3,716 | 4,597 |
United Kingdom | ||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Total long-lived assets | 3,470 | 2,797 |
Rest of world | ||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Total long-lived assets | $ 8,202 | $ 4,219 |
Restructuring and Other Relat_3
Restructuring and Other Related Charges - Additional Information (Details) - USD ($) $ in Thousands | 12 Months Ended | |||
Nov. 30, 2022 | Apr. 30, 2024 | Apr. 30, 2023 | Apr. 30, 2022 | |
Restructuring Cost and Reserve [Line Items] | ||||
Restructuring and other related charges | $ 4,917 | $ 31,297 | $ 0 | |
Asset impairment charges | 0 | 6,242 | $ 0 | |
Impairment charges | 0 | |||
Leased Office Space | ||||
Restructuring Cost and Reserve [Line Items] | ||||
Asset impairment charges | 5,100 | |||
Furniture, Equipment, And Leasehold Improvements | ||||
Restructuring Cost and Reserve [Line Items] | ||||
Impairment charges | 1,100 | |||
Employee Severance | ||||
Restructuring Cost and Reserve [Line Items] | ||||
Incurred charges | 4,217 | |||
Restructuring and other related charges | $ 800 | 23,300 | ||
Decrease in workforce (as a percent) | 13% | |||
Facilities-related charges | $ 6,200 |
Restructuring and Other Relat_4
Restructuring and Other Related Charges - Summary of Restructuring Activities (Details) - Employee Severance $ in Thousands | 12 Months Ended |
Apr. 30, 2024 USD ($) | |
Restructuring Cost and Reserve [Line Items] | |
Beginning balance | $ 0 |
Incurred during the period | 4,217 |
Paid during the period | (589) |
Foreign currency translation adjustment | (2) |
Ending balance | $ 3,626 |